The	O
gender	O
ratios	O
are	O
identical	O
in	O
both	O
case	O
and	O
control	O
groups	O
(	O
male	O
to	O
female	O
is	O
53	M-PER
%	O
to	O
47	F-PER
%	O
)	O
and	O
the	O
age	O
of	O
populations	O
are	O
38	O
±	O
13.7	O
and	O
26.4	O
±	O
7.9	O
in	O
case	O
and	O
control	O
groups	O
,	O
respectively	O
.	O

Materials	O
and	O
methodsPatientsThe	O
subject	O
group	O
consisted	O
of	O
49	F-NUM
women	O
(	O
29	O
to	O
44	O
years	O
old	O
)	O
for	O
whom	O
in	O
vitro	O
fertilization	O
(	O
IVF	O
)	O
treatment	O
was	O
indicated	O
.	O

[	O
21	O
]	O
with	O
an	O
additional	O
correction	O
for	O
Asians	O
[	O
22	O
]	O
:	O
where	O
Sex	O
is	O
0	F-NUM
for	O
females	O
and	O
1	M-NUM
for	O
males	O
,	O
Asian	O
is	O
1	O
for	O
Asians	O
and	O
0	O
for	O
others	O
,	O
Age	O
is	O
in	O
years	O
and	O
BMI	O
=	O
weight/height2	O
(	O
kg/m2	O
)	O
.	O

This	O
value	O
of	O
Tclr	O
corresponds	O
to	O
a	O
steady	O
state	O
liver	O
clearance	O
of	O
1.49	O
liters/min	O
or	O
83	O
%	O
of	O
the	O
total	O
liver	O
flow	O
for	O
the	O
standard	O
70	O
kg	O
man	O
(	O
see	O
Table	O
2	O
)	O
.	O

The	O
MDA-MB-231	O
cells	O
were	O
harvested	O
from	O
exponential	O
cultures	O
and	O
inoculated	O
at	O
2	O
×	O
106cells/inoculum	O
in	O
the	O
inguinal	O
mammary	O
fat	O
pad	O
area	O
of	O
160	F-NUM
female	O
athymic	O
nude	O
mice	O
,	O
6	O
weeks	O
of	O
age	O
(	O
purchased	O
from	O
the	O
Harlan	O
Sprague	O
Dawley	O
,	O
Inc.	O
,	O
Indianapolis	O
,	O
IN	O
)	O
.	O

There	O
were	O
2	M-NUM
men	O
and	O
6	F-NUM
women	O
:	O
ages	O
ranged	O
from	O
19	O
to	O
67	O
years	O
old	O
(	O
mean	O
54.8	O
years	O
)	O
.	O

Specific	O
diagnoses	O
are	O
listed	O
for	O
each	O
participant	O
in	O
Table	O
2.Table	O
1Subject	O
characteristicsAge	O
(	O
yrs	O
)	O
Height	O
(	O
m	O
)	O
Weight	O
(	O
kg	O
)	O
*	O
Healthy	O
Participants	O
(	O
5	F-NUM
females	O
)	O
Mean43.41.5853.6St	O
.	O

Dev.15.5.185.0Range24.2	O
–	O
59.581.22	O
–	O
1.7345.0	O
–	O
59.1Vestibular	O
Hypofunction	O
Participants	O
(	O
5	F-NUM
females	O
,	O
1	M-NUM
male	O
)	O
Mean45.31.6792.6St	O
.	O

Dev.10.2.0928.7Range29.92	O
–	O
61.601.55	O
–	O
1.8354.55	O
–	O
145.45Cerebellar	O
Pathology	O
Participants	O
(	O
2	F-NUM
females	O
,	O
1	M-NUM
male	O
)	O
Mean55.611.6373.87St	O
.	O

MethodsSubjectsSeventy-five	O
adult	O
subjects	O
(	O
37	M-NUM
males	O
and	O
38	F-NUM
females	O
)	O
ranging	O
in	O
age	O
from	O
18–40	O
years	O
old	O
gave	O
their	O
informed	O
consent	O
to	O
participate	O
in	O
the	O
study	O
.	O

MethodsMaterialA	O
total	O
of	O
42	F-NUM
women	O
undergoing	O
singleton	O
pregnancies	O
were	O
included	O
in	O
the	O
present	O
study	O
.	O

The	O
two	O
preterm	O
groups	O
included	O
15	F-NUM
women	O
in	O
preterm	O
labour	O
,	O
(	O
PTL	O
)	O
and	O
5	O
in	O
preterm	O
not	O
in	O
labour	O
(	O
PTnotL	O
)	O
,	O
delivered	O
by	O
caesarean	O
section	O
before	O
the	O
onset	O
of	O
labour	O
.	O

Each	O
preterm	O
group	O
was	O
compared	O
with	O
the	O
same	O
group	O
at	O
term	O
:	O
14	F-NUM
women	O
in	O
term	O
labour	O
(	O
TL	O
)	O
and	O
8	O
in	O
term	O
not	O
in	O
labour	O
caesarean	O
section	O
(	O
TnotL	O
)	O
.	O

Their	O
mean	O
age	O
was	O
67.2	O
yr	O
(	O
range	O
56–74	O
yr	O
)	O
(	O
6	F-NUM
women	O
and	O
4	M-NUM
men	O
)	O
.	O

Overall	O
,	O
the	O
sample	O
was	O
66	M-PER
%	O
male	O
,	O
with	O
a	O
mean	O
age	O
at	O
death	O
of	O
44	O
y	O
(	O
standard	O
deviation	O
[	O
SD	O
]	O
8.9	O
y	O
,	O
range	O
19–64	O
y	O
)	O
,	O
and	O
was	O
predominantly	O
Caucasian	O
(	O
97	O
%	O
)	O
.	O

One	O
hundred	O
and	O
sixty	O
five	O
premenopausal	O
(	O
≤	O
45	O
years	O
)	O
women	O
,	O
from	O
Kashmir	O
region	O
of	O
India	O
,	O
were	O
studied	O
for	O
sonographic	O
suggestion	O
of	O
PCO	O
in	O
addition	O
to	O
recording	O
of	O
clinical	O
,	O
biochemical	O
and	O
hormonal	O
manifestations	O
of	O
PCOS	O
.	O

Patient	O
group	O
:	O
This	O
group	O
comprised	O
of	O
105	F-NUM
non-pregnant	O
women	O
with	O
T2DM	O
of	O
at	O
least	O
one	O
year	O
duration	O
treated	O
with	O
medical	O
nutrition	O
therapy	O
and/or	O
oral	O
hypoglycemic	O
drugs	O
.	O

The	O
samples	O
were	O
taken	O
in	O
early	O
follicular	O
phase	O
(	O
day	O
3	O
–	O
day	O
5	O
)	O
in	O
women	O
with	O
regular	O
cycles	O
in	O
all	O
subjects	O
and	O
controls.c	O
.	O

Analysis	O
of	O
Oocyte-Counting	O
DataUsing	O
the	O
above	O
algorithms	O
,	O
we	O
have	O
analyzed	O
published	O
oocyte	O
counts	O
from	O
102	F-NUM
human	O
females	O
[	O
16,19	O
]	O
.	O

data	O
[	O
5	F-NUM
]	O
represents	O
the	O
mean	O
values	O
for	O
4	M-NUM
male	O
and	O
5	O
female	O
healthy	O
subjects	O
undergoing	O
donor	O
nephrectomy	O
.	O

[	O
32	O
]	O
exposed	O
26	M-NUM
male	O
Caucasian	O
subjects	O
to	O
50	O
ppm	O
each	O
of	O
1H8-toluene	O
and	O
2H8-toluene	O
for	O
two	O
hours	O
at	O
rest	O
,	O
and	O
collected	O
venous	O
blood	O
and	O
alveolar	O
breath	O
samples	O
for	O
up	O
to	O
120	O
hours	O
.	O

The	O
study	O
population	O
comprised	O
42	F-NUM
women	O
with	O
premature	O
ovarian	O
failure	O
and	O
10	O
normal	O
healthy	O
control	O
women	O
who	O
had	O
regular	O
menses	O
and	O
proven	O
fertility	O
.	O

There	O
were	O
16	M-NUM
males	O
and	O
70	F-NUM
females	O
.	O

The	O
initial	O
sequencing	O
project	O
analyzed	O
the	O
complete	O
sequence	O
of	O
NRIP1	O
gene	O
in	O
20	F-NUM
independent	O
DNA	O
samples	O
obtained	O
from	O
fresh	O
endometriotic	O
tissue	O
derived	O
from	O
peritoneal	O
implants	O
or	O
endometrioma	O
lesions	O
of	O
20	O
unrelated	O
women	O
with	O
severe	O
endometriosis	O
.	O

i	O
)	O
We	O
increase	O
the	O
sample	O
size	O
of	O
the	O
case	O
group	O
(	O
endometriosis	O
group	O
)	O
three-fold	O
using	O
germ-line	O
DNA	O
derived	O
from	O
blood	O
of	O
39	F-NUM
additional	O
women	O
affected	O
by	O
severe	O
endometriosis	O
(	O
Stage	O
III-IV	O
)	O
.	O

For	O
quality	O
control	O
,	O
we	O
excluded	O
bone	O
lead	O
measurements	O
with	O
uncertainty	O
estimates	O
that	O
were	O
>	O
10	O
and	O
15	O
μg	O
lead/g	O
mineral	O
bone	O
for	O
tibia	O
(	O
n	O
=	O
12	O
)	O
and	O
patella	O
(	O
n	O
=	O
38	O
)	O
,	O
respectively	O
,	O
from	O
the	O
entire	O
cohort	O
of	O
629	F-NUM
women	O
.	O

The	O
mean	O
±	O
SD	O
excretion	O
of	O
urine	O
was	O
79	O
±	O
36	O
mL/hr	O
in	O
men	O
and	O
78	O
±	O
37	O
mL/hr	O
in	O
women.Statistics.For	O
all	O
the	O
parameters	O
determined	O
,	O
the	O
observations	O
below	O
the	O
detection	O
limits	O
were	O
recorded	O
as	O
half	O
of	O
the	O
detection	O
limit	O
.	O

Enrollment	O
stopped	O
when	O
24	F-NUM
males	O
and	O
24	O
females	O
who	O
met	O
the	O
inclusion	O
criteria	O
were	O
enrolled.To	O
meet	O
the	O
criteria	O
for	O
the	O
study	O
,	O
subjects	O
were	O
required	O
to	O
be	O
healthy	O
adults	O
.	O

It	O
described	O
measurements	O
of	O
the	O
plasma	O
propranolol	O
concentration	O
from	O
1	O
minute	O
to	O
8	O
hours	O
after	O
a	O
0.05	O
mg/Kg	O
dose	O
infused	O
at	O
a	O
rate	O
of	O
1	O
mg/min	O
in	O
6	M-NUM
young	O
normal	O
males	O
(	O
weight	O
60–90	O
Kg	O
)	O
.	O

The	O
subjects	O
were	O
6	M-NUM
healthy	O
males	O
weighing	O
70	O
to	O
100	O
Kg	O
.	O

[	O
25	O
]	O
of	O
the	O
plasma	O
propranolol	O
concentration	O
after	O
oral	O
administration	O
of	O
60	O
mg	O
of	O
either	O
conventional	O
or	O
long	O
acting	O
propranolol	O
(	O
Inderal	O
LA	O
)	O
to	O
10	O
healthy	O
subjects	O
(	O
4	F-NUM
females	O
,	O
6	M-NUM
males	O
,	O
average	O
weight	O
of	O
59.1	O
Kg	O
)	O
.The	O
mean	O
plasma	O
concentrations	O
at	O
each	O
time	O
point	O
were	O
used	O
for	O
the	O
PBPK	O
fitting	O
.	O

In	O
brief	O
,	O
26	O
patients	O
with	O
CFS	O
(	O
23	F-NUM
women	O
and	O
3	M-NUM
men	O
)	O
were	O
recruited	O
from	O
a	O
physician	O
surveillance	O
study	O
in	O
Atlanta	O
[	O
26	O
]	O
.	O

Materials	O
and	O
methodsSubjectsEutopic	O
endometrial	O
tissue	O
was	O
obtained	O
from	O
30	O
women	O
undergoing	O
laparatomy	O
for	O
endometriosis	O
associated	O
with	O
chronic	O
pelvic	O
pain	O
,	O
severe	O
dysmenorrhea	O
and	O
infertility	O
,	O
and	O
from	O
34	F-NUM
eumenorrheic	O
women	O
undergoing	O
laparoscopy	O
for	O
tubal	O
sterilization	O
.	O

Our	O
Caucasian	O
study	O
comprised	O
188	O
unrelated	O
nondiabetic	O
control	O
individuals	O
(	O
73	M-NUM
male	O
,	O
115	F-NUM
female	O
)	O
and	O
190	O
individuals	O
with	O
T2DM	O
(	O
133	O
male	O
,	O
57	O
female	O
)	O
,	O
and	O
has	O
been	O
described	O
previously	O
[	O
20	O
]	O
.	O

Initial	O
case-control	O
studies	O
in	O
African	O
Americans	O
were	O
conducted	O
on	O
165	O
control	O
individuals	O
(	O
82	O
male	O
,	O
83	O
female	O
)	O
and	O
255	O
diabetic	O
cases	O
(	O
142	M-NUM
male	O
,	O
113	F-NUM
female	O
)	O
.	O

Hence	O
,	O
for	O
these	O
markers	O
we	O
present	O
data	O
for	O
on	O
186	M-NUM
African	O
American	O
controls	O
(	O
95	O
male	O
,	O
91	O
female	O
)	O
and	O
341	O
African	O
American	O
diabetic	O
individuals	O
(	O
186	O
male	O
,	O
155	F-NUM
female	O
)	O
.	O

Of	O
the	O
total	O
1,006	F-NUM
newly	O
married	O
women	O
,	O
35	O
women	O
were	O
ineligible	O
,	O
10	O
women	O
refused	O
,	O
and	O
961	O
women	O
were	O
enrolled	O
;	O
99	O
%	O
of	O
them	O
did	O
not	O
smoke	O
.	O

Hormone	O
assays	O
were	O
performed	O
for	O
387	F-NUM
women	O
who	O
had	O
provided	O
sufficient	O
diary	O
and	O
urine	O
samples	O
and	O
who	O
did	O
not	O
smoke	O
.	O

Of	O
the	O
total	O
1,484	O
cycles	O
from	O
the	O
387	F-NUM
women	O
,	O
804	O
cycles	O
were	O
selected	O
for	O
urinary	O
hormone	O
analysis	O
.	O

As	O
a	O
result	O
,	O
a	O
total	O
of	O
673	O
cycles	O
from	O
371	F-NUM
women	O
were	O
included	O
in	O
the	O
subsequent	O
analysis	O
.	O

Briefly	O
,	O
urine	O
samples	O
from	O
37	F-NUM
control	O
women	O
who	O
were	O
not	O
at	O
risk	O
for	O
conception	O
were	O
collected	O
for	O
serving	O
nonconception	O
controls	O
cycles	O
,	O
and	O
urine	O
samples	O
from	O
cycles	O
ending	O
with	O
clinical	O
pregnancy	O
were	O
used	O
for	O
conception	O
control	O
cycles	O
.	O

Materials	O
and	O
MethodsCancer	O
Incidence	O
DataWe	O
identified	O
all	O
invasive	O
breast	O
cancer	O
cases	O
diagnosed	O
in	O
women	O
≥	O
20	O
years	O
of	O
age	O
from	O
the	O
California	O
Cancer	O
Registry	O
(	O
CCR	O
)	O
,	O
for	O
1988	O
through	O
1997	O
(	O
n	O
=	O
181,080	O
)	O
(	O
CCR	O
2005	O
)	O
.	O

After	O
great	O
persistence	O
,	O
however	O
,	O
a	O
group	O
of	O
55	O
people	O
comprising	O
32	M-NUM
males	O
and	O
23	F-NUM
females	O
(	O
Group	O
I	O
,	O
Table	O
1	O
)	O
living	O
in	O
this	O
village	O
agreed	O
to	O
become	O
subjects	O
of	O
a	O
double-blind	O
placebo-controlled	O
trial	O
only	O
for	O
analyzing	O
urine	O
As	O
content	O
for	O
a	O
few	O
days	O
(	O
11	O
days	O
only	O
)	O
.	O

Blood	O
samples	O
were	O
collected	O
from	O
187	O
Japanese	O
patients	O
with	O
RA	O
(	O
mean	O
age	O
46	O
±	O
17	O
years	O
;	O
33	F-NUM
females	O
;	O
mean	O
disease	O
duration	O
12.9	O
years	O
[	O
range	O
1–46	O
years	O
]	O
)	O
including	O
four	O
with	O
vasculitis	O
and	O
three	O
with	O
Felty	O
's	O
syndrome	O
.	O

In	O
addition	O
,	O
158	O
Japanese	O
volunteers	O
(	O
mean	O
age	O
30	O
±	O
9	O
years	O
;	O
105	F-NUM
females	O
)	O
were	O
recruited	O
from	O
our	O
institute	O
to	O
serve	O
as	O
a	O
healthy	O
comparison	O
group	O
.	O

Materials	O
and	O
methodsPatients	O
and	O
tissue	O
specimensSera	O
from	O
Caucasian	O
patients	O
with	O
SSc	O
(	O
n	O
=	O
41	O
;	O
29	O
female	O
,	O
12	O
male	O
;	O
mean	O
age	O
58.2	O
±	O
14.3	O
years	O
)	O
and	O
from	O
healthy	O
Caucasian	O
controls	O
(	O
n	O
=	O
44	O
;	O
31	F-NUM
female	O
,	O
13	M-NUM
male	O
;	O
mean	O
age	O
46.9	O
±	O
19.8	O
years	O
)	O
were	O
studied	O
.	O

MethodsPatients	O
and	O
ControlsEighty-one	O
SSc	O
patients	O
(	O
75	F-NUM
women	O
and	O
six	O
men	O
,	O
mean	O
±	O
standard	O
deviation	O
age	O
54.5	O
±	O
14.1	O
y	O
)	O
from	O
northern	O
Italy	O
were	O
studied	O
.	O

The	O
Cylindrical	O
cages	O
(	O
BAK	O
)	O
.Specimen	O
preparationTen	O
functional	O
spinal	O
units	O
(	O
FSU	O
;	O
five	O
L2-L3	O
,	O
five	O
L4-L5	O
)	O
of	O
human	O
cadaver	O
lumbar	O
spine	O
from	O
5	O
subjects	O
(	O
3	M-NUM
male	O
,	O
2	F-NUM
female	O
)	O
were	O
tested	O
.	O

We	O
obtained	O
morning	O
spot	O
urine	O
from	O
813	F-NUM
women	O
and	O
blood	O
samples	O
from	O
742	O
.	O

Seventy-five	O
residents	O
(	O
47	F-NUM
females	O
,	O
28	M-NUM
males	O
)	O
consented	O
.	O

However	O
,	O
since	O
only	O
42	M-NUM
men	O
were	O
included	O
in	O
our	O
sample	O
,	O
to	O
avoid	O
overfitting	O
,	O
multivariate	O
analysis	O
was	O
considered	O
not	O
appropriate.Analysis	O
was	O
conducted	O
in	O
SPSS	O
10.0	O
(	O
SPSS	O
Inc.	O
Chicago	O
,	O
IL	O
)	O
.	O

Data	O
from	O
these	O
samplings	O
were	O
not	O
included	O
in	O
the	O
modeling	O
of	O
half-lives	O
but	O
are	O
reported	O
separately.Clerks.In	O
June	O
1997	O
blood	O
samples	O
were	O
obtained	O
from	O
20	F-NUM
female	O
clerks	O
,	O
25–61	O
years	O
of	O
age	O
,	O
regularly	O
using	O
computers	O
8	O
hr/day	O
(	O
Sjödin	O
et	O
al	O
.	O

Samples	O
from	O
their	O
vacation	O
period	O
were	O
not	O
obtained.Cleaners.In	O
September	O
1997	O
,	O
blood	O
samples	O
were	O
obtained	O
from	O
20	F-NUM
female	O
hospital	O
cleaners	O
30–60	O
years	O
of	O
age	O
(	O
Sjödin	O
et	O
al	O
.	O

Samples	O
from	O
their	O
vacation	O
periods	O
were	O
not	O
obtained.Abattoir	O
workers.Blood	O
samples	O
were	O
obtained	O
from	O
18	M-NUM
male	O
abattoir	O
workers	O
24–60	O
years	O
of	O
age	O
in	O
March	O
2000	O
(	O
Thuresson	O
et	O
al	O
.	O

Materials	O
and	O
methodsArchival	O
tissue	O
materialTwenty	O
eight	O
primary	O
squamous	O
cell	O
carcinomas	O
(	O
16	M-NUM
males	O
and	O
12	F-NUM
females	O
)	O
of	O
the	O
tongue	O
tumor	O
were	O
retrieved	O
from	O
the	O
Tumor	O
Bank	O
of	O
the	O
Greenebaum	O
Cancer	O
Center	O
,	O
University	O
of	O
Maryland	O
Baltimore	O
.	O

There	O
were	O
3	F-NUM
females	O
and	O
2	M-NUM
males	O
in	O
each	O
group	O
ranging	O
in	O
age	O
from	O
16	O
to	O
49	O
years	O
.	O

[	O
38	O
]	O
of	O
a	O
3	O
way	O
crossover	O
trial	O
using	O
12	M-NUM
healthy	O
young	O
(	O
19	O
to	O
28	O
years	O
)	O
,	O
non-obese	O
(	O
average	O
weight	O
=	O
76.25	O
kg	O
and	O
height	O
=	O
1.86	O
,	O
BMI	O
19.9	O
to	O
24	O
)	O
males	O
[	O
38	O
]	O
.	O

MethodsSubjectsUmbilical	O
cord	O
blood	O
was	O
obtained	O
from	O
92	O
subjects	O
consisting	O
of	O
53	M-NUM
males	O
and	O
39	F-NUM
females	O
,	O
who	O
were	O
born	O
at	O
The	O
Johns	O
Hopkins	O
Hospital	O
.	O

We	O
evaluated	O
only	O
men	O
age	O
40	O
years	O
and	O
older	O
at	O
the	O
time	O
of	O
initial	O
testing	O
.	O

The	O
drug-dependent	O
women	O
focus	O
groups	O
,	O
conducted	O
in	O
shelters	O
or	O
treatment	O
facilities	O
,	O
included	O
pregnant	O
and	O
postpartum	O
women	O
(	O
n	O
=	O
33	O
)	O
and	O
women	O
of	O
childbearing	O
age	O
(	O
n	O
=	O
12	O
)	O
.	O

The	O
homeless	O
women	O
focus	O
groups	O
,	O
conducted	O
in	O
shelters	O
,	O
included	O
pregnant	O
and	O
postpartum	O
women	O
(	O
n	O
=	O
29	O
)	O
and	O
women	O
of	O
childbearing	O
age	O
with	O
at	O
least	O
one	O
child	O
(	O
n	O
=	O
22	O
)	O
.	O

MethodsSubjects	O
,	O
bronchoalveolar	O
lavage	O
,	O
and	O
sampling	O
of	O
lung	O
tissuePatients	O
suffering	O
from	O
SSc	O
and	O
alveolitis	O
(	O
n	O
=	O
10	O
,	O
4	M-NUM
male/6	O
female	O
)	O
aged	O
29–69	O
diagnosed	O
by	O
HRCT	O
were	O
included	O
in	O
the	O
study	O
.	O

The	O
patients	O
were	O
not	O
treated	O
with	O
any	O
putative	O
disease	O
modifying	O
drugs.Patients	O
with	O
mild	O
asthma	O
with	O
BALF	O
fibroblasts	O
(	O
n	O
=	O
5	O
,	O
4	F-NUM
female/1	O
male	O
)	O
fulfilled	O
the	O
criteria	O
of	O
the	O
American	O
Thoracic	O
Society	O
.	O

MethodsStudy	O
populationWe	O
have	O
studied	O
498	F-NUM
women	O
seeking	O
for	O
cervical	O
Papanicolaou	O
examination	O
and	O
attending	O
three	O
public	O
health	O
centers	O
of	O
Durango	O
City	O
,	O
Mexico	O
.	O

Muscle	O
biopsies	O
from	O
a	O
separate	O
group	O
of	O
5	O
adult	O
untreated	O
female	O
DM	O
patients	O
(	O
age	O
,	O
years	O
:	O
48.5	O
±	O
14.8	O
)	O
were	O
profiled	O
and	O
compared	O
to	O
muscle	O
tissue	O
of	O
normal	O
human	O
muscle	O
(	O
NHM	O
)	O
from	O
four	O
healthy	O
volunteers	O
(	O
age	O
,	O
years	O
:	O
43.5	O
±	O
12.1	O
)	O
.	O

There	O
were	O
15	F-NUM
female	O
(	O
18.75	O
%	O
)	O
and	O
65	M-NUM
males	O
(	O
81.25	O
%	O
)	O
aged	O
between	O
14	O
to	O
76	O
years	O
(	O
median	O
39	O
years	O
)	O
.	O

All	O
members	O
of	O
control	O
group	O
had	O
no	O
previous	O
history	O
of	O
TB	O
,	O
no	O
signs	O
or	O
symptoms	O
suggestive	O
of	O
pulmonary	O
TB	O
,	O
no	O
evidence	O
of	O
TB	O
on	O
chest	O
X	O
rays.The	O
54	O
subjects	O
selected	O
for	O
the	O
control	O
group	O
had	O
a	O
median	O
age	O
of	O
41	O
years	O
(	O
age	O
range	O
,	O
18–75	O
years	O
)	O
and	O
43	M-NUM
(	O
79.6	O
%	O
)	O
were	O
males	O
,	O
11	F-NUM
(	O
20.4	O
%	O
)	O
were	O
females	O
.	O

Among	O
them	O
,	O
71	F-NUM
are	O
females	O
and	O
57	M-NUM
are	O
males	O
.	O

Human	O
ovaries	O
were	O
collected	O
from	O
women	O
,	O
23	O
to	O
45	O
years	O
of	O
age	O
,	O
undergoing	O
oophorectomy	O
for	O
non-neoplastic	O
indications	O
.	O

The	O
offspring	O
group	O
consisted	O
of	O
122	F-NUM
females	O
and	O
94	M-NUM
males	O
(	O
age	O
68.3	O
[	O
0.45	O
]	O
y	O
,	O
range	O
51–89	O
y	O
)	O
.	O

The	O
study	O
sample	O
included	O
183	O
participants	O
with	O
mean	O
age	O
71.3	O
(	O
0.67	O
)	O
y	O
,	O
57	F-NUM
%	O
female	O
[	O
47	O
]	O
.	O

Spouses	O
of	O
offspring	O
included	O
75	O
participants	O
with	O
mean	O
age	O
70.2	O
(	O
1.17	O
)	O
y	O
,	O
53	F-NUM
%	O
female	O
.	O

In	O
addition	O
,	O
15	F-NUM
healthy	O
female	O
donors	O
,	O
24	O
to	O
73	O
years	O
of	O
age	O
,	O
volunteered	O
for	O
the	O
study	O
and	O
served	O
as	O
controls	O
.	O

Of	O
the	O
1273	F-NUM
women	O
,	O
DNA	O
was	O
available	O
for	O
analysis	O
in	O
89	O
women	O
of	O
the	O
121	O
who	O
developed	O
pre-eclampsia	O
.	O

Baseline	O
characteristics	O
of	O
the	O
32	F-NUM
women	O
that	O
were	O
not	O
included	O
in	O
the	O
DNA	O
analysis	O
for	O
logistical	O
reasons	O
were	O
not	O
significantly	O
different	O
from	O
the	O
89	O
cases	O
included	O
in	O
the	O
present	O
report	O
(	O
Data	O
not	O
shown	O
)	O
.	O

Of	O
the	O
1152	F-NUM
women	O
who	O
did	O
not	O
develop	O
pre-eclampsia	O
,	O
349	O
women	O
(	O
ratio	O
1:4	O
)	O
were	O
selected	O
as	O
controls	O
using	O
frequency	O
matching	O
by	O
maternal	O
age	O
and	O
ethnic	O
background.Pre-eclampsia	O
was	O
defined	O
according	O
to	O
the	O
International	O
Society	O
for	O
the	O
Study	O
of	O
Hypertension	O
in	O
Pregnancy	O
[	O
26	O
]	O
.	O

Cartilage	O
samples	O
were	O
obtained	O
from	O
a	O
total	O
of	O
10	O
subjects	O
,	O
6	F-NUM
females	O
and	O
4	M-NUM
males	O
,	O
representing	O
several	O
racial	O
groups	O
(	O
Hispanic	O
,	O
African-American	O
and	O
Caucasian	O
,	O
with	O
a	O
mean	O
age	O
of	O
62	O
yrs	O
)	O
.	O

The	O
response	O
rate	O
was	O
87	O
%	O
;	O
a	O
total	O
of	O
599	O
persons	O
(	O
397	F-NUM
women	O
and	O
202	M-NUM
men	O
)	O
participated	O
[	O
13	O
]	O
.	O

The	O
age	O
of	O
the	O
patients	O
(	O
1	F-NUM
female	O
and	O
19	M-NUM
male	O
)	O
were	O
from	O
38	O
to	O
73	O
years	O
old	O
with	O
the	O
mean	O
age	O
of	O
59	O
±	O
14	O
.	O

A	O
total	O
of	O
30	O
groups	O
(	O
389	O
farmers	O
:	O
164	F-NUM
women	O
and	O
225	M-NUM
men	O
)	O
were	O
interviewed	O
.	O

6	O
month	O
old	O
male	O
Sprague-Dawley	O
rats	O
were	O
sacrificed	O
by	O
asphyxiation	O
using	O
CO2	O
.	O

The	O
majority	O
had	O
at	O
least	O
two	O
of	O
the	O
APS1	O
triad	O
(	O
see	O
Table	O
2	O
for	O
endocrine	O
disorders	O
and	O
Table	O
1	O
for	O
CMC	O
)	O
,	O
although	O
one	O
male	O
aged	O
35	O
y	O
had	O
only	O
AD	O
(	O
[	O
22	O
]	O
;	O
see	O
footnote	O
“	O
e	O
”	O
of	O
Table	O
1	O
)	O
.	O

MethodsSubjectsBlood	O
samples	O
from	O
3	F-NUM
female	O
and	O
4	M-NUM
male	O
volunteers	O
were	O
obtained	O
after	O
informed	O
consent	O
.	O

We	O
obtained	O
morning	O
spot	O
urine	O
from	O
797	F-NUM
women	O
and	O
blood	O
from	O
727	M-NUM
women	O
.	O

Fine	O
needle	O
aspirate	O
sample	O
from	O
28	O
year-old	O
female	O
with	O
thyroid	O
nodule	O
.	O

There	O
were	O
6	M-NUM
males	O
and	O
10	F-NUM
females	O
(	O
62.5	O
%	O
)	O
,	O
a	O
somewhat	O
higher	O
representation	O
of	O
women	O
than	O
in	O
the	O
student	O
body	O
as	O
a	O
whole	O
(	O
50.0	O
%	O
)	O
;	O
and	O
17.7	O
%	O
underrepresented	O
minorities	O
,	O
compared	O
to	O
10.0	O
%	O
overall	O
.	O

Briefly	O
,	O
follicle	O
samples	O
were	O
obtained	O
from	O
an	O
ovarian	O
cortex	O
biopsy	O
donated	O
for	O
research	O
(	O
22	O
year-old	O
woman	O
)	O
,	O
and	O
were	O
measured	O
and	O
staged	O
microscopically	O
.	O

MethodsBrainstem	O
material	O
was	O
obtained	O
from	O
four	O
adult	O
human	O
brains	O
with	O
no	O
previous	O
history	O
of	O
neurological	O
or	O
psychiatric	O
disease	O
(	O
two	O
men	O
,	O
81	O
and	O
82	O
years	O
;	O
two	O
women	O
,	O
84	O
and	O
87	O
years	O
)	O
,	O
who	O
died	O
from	O
renal	O
failure	O
,	O
anaemia	O
,	O
or	O
myocardial	O
infarct	O
.	O

Either	O
50	O
or	O
100	F-NUM
female	O
mosquitoes	O
,	O
starved	O
for	O
6	O
hours	O
,	O
were	O
used	O
in	O
each	O
experiment.The	O
number	O
of	O
mosquitoes	O
caught	O
in	O
each	O
trap	O
chamber	O
was	O
considered	O
as	O
having	O
been	O
attracted	O
by	O
the	O
person	O
sleeping	O
in	O
the	O
adjacent	O
tent	O
.	O

The	O
study	O
was	O
conducted	O
on	O
8	F-NUM
healthy	O
female	O
adult	O
Micro-Yucatan	O
Miniature	O
swine	O
(	O
Sus	O
scrofa	O
domesticus	O
)	O
,	O
selected	O
on	O
the	O
basis	O
of	O
their	O
use	O
in	O
other	O
published	O
research	O
and	O
their	O
similarity	O
of	O
wound	O
healing	O
to	O
humans	O
.	O

These	O
groups	O
included	O
40	F-NUM
women	O
of	O
different	O
stages	O
of	O
pregnancy	O
(	O
10	M-NUM
each	O
in	O
Ist	O
,	O
IInd	O
,	O
IIIrd	O
trimesters	O
and	O
post	O
delivery	O
period	O
)	O
,	O
20	O
women	O
with	O
RSA	O
(	O
10	O
each	O
of	O
pre	O
and	O
post	O
immunization	O
)	O
,	O
10	O
healthy	O
males	O
and	O
10	O
unmarried	O
non-pregnant	O
females	O
.	O

IgG	O
was	O
also	O
isolated	O
from	O
10	F-NUM
males	O
,	O
10	O
women	O
with	O
RSA	O
and	O
10	O
unmarried	O
non-pregnant	O
females	O
(	O
who	O
had	O
no	O
MLR-Bf	O
activity	O
)	O
.	O

The	O
listeners	O
were	O
two	O
males	O
and	O
two	O
females	O
(	O
22	O
to	O
24	O
years	O
old	O
)	O
and	O
had	O
normal	O
hearing	O
as	O
determined	O
by	O
preceding	O
measurements	O
of	O
absolute	O
thresholds	O
.	O

2001	O
)	O
,	O
conducted	O
in	O
an	O
area	O
with	O
no	O
particular	O
industrial	O
emission	O
,	O
we	O
assessedhealth	O
effects	O
of	O
Cd	O
in	O
820	F-NUM
women	O
53–64	O
years	O
of	O
age	O
(	O
Åkesson	O
et	O
al	O
.	O

Cannabis	O
users	O
were	O
consecutively	O
admitted	O
into	O
the	O
study	O
if	O
the	O
cannabis	O
use	O
began	O
prior	O
to	O
the	O
age	O
of	O
18	O
and	O
consisted	O
of	O
use	O
more	O
than	O
21	O
times	O
in	O
any	O
single	O
year	O
(	O
N	O
=	O
10	O
;	O
9	M-NUM
males	O
,	O
1	F-NUM
female	O
,	O
mean	O
age	O
21.1	O
±	O
2.9	O
,	O
range	O
18–27	O
)	O
.	O

The	O
10	O
matched	O
non-user	O
controls	O
were	O
9	M-NUM
males	O
and	O
1	F-NUM
female	O
,	O
mean	O
age	O
of	O
23.0	O
±	O
4.4	O
(	O
range	O
:	O
17–30	O
)	O
.	O

MethodsSubjects	O
and	O
pulmonary	O
function	O
testingA	O
group	O
of	O
healthy	O
subjects	O
was	O
studied	O
(	O
Table	O
1	O
)	O
with	O
40	O
to	O
65	O
years	O
of	O
age	O
(	O
12	M-NUM
men	O
,	O
five	O
women	O
)	O
,	O
which	O
was	O
divided	O
into	O
never	O
smokers	O
(	O
NS	O
)	O
and	O
asymptomatic	O
smokers	O
(	O
S	O
)	O
.	O

SUBJECTS	O
AND	O
METHODSStudy	O
populationForty	O
patients	O
with	O
IS	O
(	O
17	F-NUM
female	O
,	O
age	O
[	O
years	O
,	O
mean	O
±	O
SD	O
]	O
:	O
67.5	O
±	O
10.5	O
)	O
and	O
64	O
patients	O
with	O
MI	O
(	O
8	M-NUM
female	O
,	O
age	O
55	O
±	O
8.8	O
)	O
were	O
entered	O
in	O
the	O
study	O
.	O

Among	O
the	O
58	O
children	O
of	O
these	O
41	O
mothers	O
,	O
45	O
children	O
had	O
a	O
CHB	O
(	O
14	M-NUM
males	O
,	O
18	F-NUM
females	O
,	O
13	O
unknowns	O
)	O
,	O
five	O
children	O
had	O
a	O
cutaneous	O
NLE	O
(	O
one	O
male	O
,	O
four	O
females	O
)	O
,	O
and	O
eight	O
children	O
were	O
healthy	O
(	O
three	O
males	O
,	O
four	O
females	O
,	O
one	O
unknown	O
)	O
.	O

Materials	O
and	O
methodsPatient	O
seraFifty-seven	O
patients	O
(	O
53	F-NUM
women	O
and	O
4	M-NUM
men	O
;	O
mean	O
age	O
at	O
baseline	O
56	O
years	O
(	O
range	O
28	O
to	O
83	O
)	O
)	O
with	O
refractory	O
RA	O
were	O
included	O
in	O
the	O
study	O
.	O

Materials	O
and	O
methodsPatientsTwenty-two	O
patients	O
with	O
active	O
SLE	O
(	O
21	F-NUM
females	O
and	O
one	O
male	O
)	O
,	O
17	O
patients	O
with	O
inactive	O
SLE	O
(	O
16	O
females	O
and	O
one	O
male	O
)	O
and	O
24	O
normal	O
control	O
individuals	O
(	O
22	O
females	O
and	O
two	O
males	O
)	O
were	O
included	O
in	O
the	O
study	O
.	O

METHODSPatientsSFs	O
were	O
obtained	O
from	O
11	O
subjects	O
with	O
RA	O
(	O
9	F-NUM
females	O
with	O
meanage	O
of	O
57	O
±	O
9	O
years	O
and	O
2	M-NUM
males	O
with	O
mean	O
age	O
of	O
55	O
±	O
6	O
years	O
)	O
and	O
6	O
subjects	O
with	O
OA	O
(	O
females	O
with	O
mean	O
age	O
of	O
65	O
±	O
5	O
years	O
)	O
.Approval	O
of	O
the	O
local	O
ethics	O
committee	O
was	O
obtained	O
prior	O
to	O
thestudy	O
.	O

The	O
first	O
groupcomprised	O
12	F-NUM
women	O
(	O
aged	O
21	O
±	O
4	O
years	O
)	O
in	O
term	O
labor	O
whounderwent	O
a	O
vaginal	O
delivery	O
.	O

Four	O
of	O
the	O
non-asthmatic	O
subjects	O
were	O
females	O
,	O
and	O
23	M-NUM
were	O
male	O
,	O
the	O
age	O
and	O
sex	O
of	O
two	O
of	O
the	O
non-asthmatic	O
subjects	O
were	O
not	O
available	O
.	O

There	O
were	O
35	F-NUM
women	O
and	O
eight	O
men	O
with	O
a	O
median	O
age	O
of	O
61	O
years	O
(	O
range	O
,	O
24–79	O
years	O
)	O
.	O

The	O
control	O
group	O
consisted	O
of	O
16	F-NUM
women	O
and	O
five	O
men	O
with	O
a	O
median	O
age	O
of	O
55	O
years	O
(	O
range	O
,	O
29–96	O
years	O
)	O
.	O

An	O
additional	O
control	O
group	O
(	O
n	O
=	O
20	O
)	O
was	O
used	O
for	O
the	O
endostatin	O
measurements	O
,	O
consisting	O
of	O
17	F-NUM
women	O
and	O
three	O
men	O
with	O
a	O
median	O
age	O
of	O
49	O
years	O
(	O
range	O
,	O
23–69	O
years	O
)	O
.	O

In	O
developing	O
the	O
questionnaire	O
,	O
in-depth	O
interviews	O
were	O
conducted	O
with	O
25	F-NUM
female	O
workers	O
at	O
Company	O
T.	O
Seven	O
public	O
health	O
professionals	O
also	O
reviewed	O
and	O
revised	O
the	O
questionnaire	O
.	O

The	O
final	O
questionnaire	O
was	O
then	O
distributed	O
in	O
August	O
and	O
September	O
2003	O
to	O
1,326	O
female	O
employees	O
,	O
whom	O
had	O
taken	O
maternity	O
leave	O
between	O
January	O
1999	O
and	O
April	O
2003	O
as	O
recorded	O
by	O
the	O
manufacturer	O
's	O
human	O
resource	O
department	O
.	O

Materials	O
and	O
methodsPopulationThese	O
research	O
data	O
were	O
collected	O
in	O
an	O
earlier	O
case–control	O
study	O
(	O
1986–1991	O
)	O
of	O
617	O
premenopausal	O
and	O
933	F-NUM
postmenopausal	O
Caucasian	O
women	O
in	O
western	O
New	O
York	O
.	O

At	O
the	O
end	O
of	O
the	O
interview	O
,	O
women	O
were	O
asked	O
to	O
provide	O
a	O
blood	O
specimen	O
;	O
45	O
%	O
of	O
premenopausal	O
women	O
and	O
63	F-NUM
%	O
of	O
postmenopausal	O
women	O
agreed	O
.	O

MethodsIsolation	O
and	O
culture	O
of	O
PWBC	O
from	O
healthy	O
human	O
volunteersPWBC	O
were	O
obtained	O
from	O
14	O
healthy	O
volunteers	O
not	O
taking	O
any	O
medication	O
(	O
8	M-NUM
male	O
,	O
6	F-NUM
female	O
;	O
aged	O
between	O
23	O
and	O
60	O
years	O
)	O
with	O
informed	O
consent	O
.	O

Anemia	O
was	O
defined	O
when	O
hemoglobin	O
<	O
13	O
g/dL	O
in	O
males	O
and	O
<	O
11.8	O
g/dL	O
in	O
females	O
.	O

Figure	O
2A	O
shows	O
the	O
VizStruct	O
mapping	O
of	O
the	O
SNPs	O
from	O
Y-chromosome	O
dataset	O
from	O
the	O
Perlegen	O
Sciences	O
database	O
(	O
)	O
wherein	O
the	O
SNPs	O
in	O
the	O
Y-chromosome	O
was	O
genotyped	O
at	O
334	O
polymorphic	O
sites	O
in	O
33	M-NUM
males	O
differing	O
in	O
race	O
:	O
11	O
African-Americans	O
,	O
13	O
European-Americans	O
and	O
9	O
Han	O
Chinese	O
(	O
17	O
)	O
.	O

MethodsPatients	O
and	O
controlsMonocytes	O
were	O
purified	O
from	O
the	O
blood	O
of	O
10	F-NUM
female	O
controls	O
and	O
10	O
female	O
T1D	O
patients	O
.	O

Overall	O
,	O
the	O
participants	O
completed	O
nearly	O
one-quarter	O
of	O
the	O
short	O
questionnaires	O
and	O
nearly	O
one-third	O
of	O
the	O
long	O
questionnaires	O
on	O
the	O
secure	O
website.A	O
total	O
of	O
84170	M-NUM
men	O
joined	O
the	O
cohort	O
,	O
and	O
nearly	O
40	O
%	O
were	O
minority	O
(	O
Table	O
2	O
)	O
.	O

METHODS	O
AND	O
MATERIALSPatients	O
and	O
blister	O
fluidsFor	O
this	O
study	O
22	O
patients	O
(	O
4	M-NUM
males	O
,	O
18	F-NUM
females	O
;	O
mean	O
age52	O
±	O
8.2	O
(	O
SD	O
)	O
years	O
)	O
were	O
selected	O
,	O
with	O
a	O
mean	O
duration	O
of	O
thedisease	O
of	O
2.75	O
±	O
1.25	O
(	O
SD	O
)	O
years	O
,	O
all	O
being	O
in	O
theintermediate	O
phase	O
.	O

PATIENTS	O
AND	O
METHODSThe	O
study	O
group	O
consisted	O
of	O
41	O
patients	O
with	O
SLE	O
(	O
38	F-NUM
females	O
and3	O
males	O
)	O
and	O
20	O
sex-	O
and	O
age-matched	O
healthy	O
volunteers	O
.	O

Paraffin	O
blocks	O
were	O
cut	O
and	O
used	O
for	O
immunohistochemistry.Ovarian	O
endometriomasEctopic	O
human	O
endometrium	O
tissues	O
were	O
obtained	O
from	O
19	F-NUM
non-menopausal	O
infertile	O
women	O
,	O
aged	O
25–37	O
years	O
from	O
ovarian	O
lesions	O
during	O
laparoscopic	O
cyst	O
enucleation	O
.	O

All	O
mice	O
were	O
female	O
between	O
5	O
and	O
7	O
weeks	O
of	O
age	O
,	O
were	O
housed	O
at	O
21	O
±	O
1°C	O
,	O
humidity	O
50	O
±	O
10	O
%	O
,	O
light/dark	O
cycle	O
of	O
12	O
hr/12	O
hr	O
,	O
and	O
had	O
free	O
access	O
to	O
pelleted	O
food	O
(	O
Rodent	O
Laboratory	O
Chow	O
,	O
Purina	O
Mills	O
,	O
Inc.	O
,	O
St.	O
Louis	O
,	O
MO	O
)	O
and	O
water	O
.	O

Thirteen	O
of	O
the	O
patients	O
were	O
males	O
and	O
7	F-NUM
were	O
females	O
with	O
a	O
mean	O
age	O
of	O
61	O
years	O
(	O
range	O
,	O
39	O
to	O
81	O
years	O
)	O
.	O

Materials	O
and	O
methodsSubjectsA	O
convenience	O
sample	O
of	O
3	M-NUM
males	O
and	O
2	F-NUM
females	O
were	O
included	O
in	O
this	O
study	O
(	O
mean	O
age	O
43.8	O
±	O
14.5	O
yrs	O
;	O
body	O
mass	O
index	O
24.1	O
±	O
2.9	O
)	O
.	O

Thymic	O
carcinoids	O
are	O
more	O
prevalent	O
in	O
males	O
than	O
in	O
females	O
[	O
26	O
]	O
,	O
while	O
bronchial	O
carcinoids	O
are	O
more	O
prevalent	O
in	O
females	O
than	O
in	O
males	O
.	O

Currently	O
,	O
the	O
determination	O
of	O
the	O
number	O
of	O
coughs	O
inside	O
each	O
cough	O
event	O
is	O
carried	O
out	O
by	O
a	O
human	O
listener.Subjects	O
and	O
sound	O
recordingThirty	O
three	O
smoking	O
subjects	O
,	O
20	M-NUM
male	O
and	O
13	F-NUM
female	O
aged	O
between	O
20	O
and	O
54	O
with	O
a	O
chronic	O
troublesome	O
cough	O
were	O
studied	O
in	O
the	O
hour	O
after	O
rising	O
.	O

Out	O
of	O
the	O
56	O
adenocarcinomas	O
(	O
other	O
than	O
mammary	O
carcinoma	O
,	O
ovarian	O
carcinoma	O
,	O
uterine	O
endometrial	O
and	O
cervical	O
carcinomas	O
of	O
the	O
female	O
gender	O
)	O
,	O
19	M-NUM
tumors	O
belonged	O
to	O
males	O
and	O
37	F-NUM
to	O
females.These	O
specimens	O
were	O
fixed	O
in	O
10	O
%	O
formalin	O
and	O
embedded	O
in	O
paraffin	O
blocks	O
.	O

Patients	O
and	O
methodsSubjectsA	O
group	O
of	O
432	O
(	O
women	O
234/men	O
198	M-NUM
)	O
patients	O
with	O
T1D	O
were	O
included	O
in	O
the	O
present	O
study	O
.	O

Thirty-one	O
out	O
of	O
53	F-NUM
women	O
with	O
threatened	O
abortion	O
(	O
group	O
A	O
)	O
were	O
dischargedafter	O
resolution	O
of	O
vaginal	O
bleeding	O
and	O
U/S	O
confirmation	O
of	O
a	O
viable	O
fetus	O
.	O

Twenty-two	O
(	O
group	O
B	O
)	O
out	O
of	O
53	F-NUM
women	O
with	O
threatened	O
abortion	O
subsequently	O
presented	O
profound	O
bleeding	O
and	O
expulsion	O
of	O
the	O
embryos	O
or	O
clinical	O
and	O
ultrasonographic	O
signs	O
of	O
nonviablepregnancy	O
after	O
7–12	O
days	O
from	O
admission	O
.	O

The	O
rest	O
22	O
out	O
of	O
75	F-NUM
women	O
of	O
the	O
same	O
gestational	O
age	O
range	O
were	O
asymptomatic	O
and	O
recruited	O
as	O
controls	O
(	O
group	O
C	O
)	O
.	O

A	O
total	O
of	O
378	O
Type	O
2	O
diabetic	O
outpatients	O
(	O
28–88	O
years	O
of	O
age	O
,	O
210	M-NUM
men	O
and	O
168	F-NUM
women	O
)	O
were	O
enrolled	O
.	O

A	O
total	O
of	O
334	O
non-diabetic	O
subjects	O
(	O
17–89	O
years	O
of	O
age	O
,	O
206	M-NUM
men	O
and	O
128	F-NUM
women	O
)	O
who	O
underwent	O
a	O
medical	O
check-up	O
in	O
our	O
hospital	O
from	O
April	O
2001	O
to	O
December	O
2003	O
served	O
as	O
the	O
control	O
group	O
.	O

The	O
total	O
length	O
of	O
sampling	O
line	O
,	O
joined	O
in	O
this	O
fashion	O
,	O
was	O
4.3	O
m.SubjectsTwo	O
tests	O
(	O
EXP	O
#	O
1	F-NUM
and	O
EXP	O
#	O
2	O
)	O
were	O
carried	O
out	O
on	O
five	O
healthy	O
,	O
non-smokers	O
(	O
4	M-NUM
males	O
and	O
1	O
female	O
)	O
,	O
aged	O
35–46	O
.	O

In	O
general	O
,	O
all	O
of	O
the	O
components	O
were	O
designed	O
,	O
with	O
strength	O
and	O
safety	O
in	O
mind	O
,	O
to	O
be	O
MR	O
compatible	O
,	O
and	O
optimized	O
for	O
regular	O
and	O
high-stress	O
testing.The	O
maximum	O
gripping	O
force	O
that	O
can	O
be	O
generated	O
by	O
the	O
hand	O
in	O
males	O
is	O
400	M-NUM
N	O
and	O
in	O
females	O
228	F-NUM
N	O
[	O
33	O
]	O
.	O

An	O
age-matched	O
normal	O
hip	O
model	O
was	O
generated	O
from	O
the	O
38	O
year	O
old	O
male	O
subject	O
of	O
the	O
Visible	O
Human	O
Project®	O
[	O
26,27	O
]	O
.	O

Patients	O
and	O
methodsStudy	O
populationUrine	O
samples	O
were	O
collected	O
as	O
the	O
morning	O
void	O
from	O
24	F-NUM
healthy	O
premenopausal	O
women	O
(	O
age	O
[	O
mean	O
±	O
standard	O
deviation	O
(	O
SD	O
)	O
]	O
,	O
33.9	O
±	O
5.6	O
years	O
)	O
and	O
31	O
healthy	O
postmenopausal	O
women	O
(	O
age	O
55.1	O
±	O
2.7	O
years	O
)	O
.	O

In	O
addition	O
,	O
123	F-NUM
female	O
patients	O
with	O
histologically	O
confirmed	O
breast	O
cancer	O
participated	O
in	O
the	O
study	O
.	O

The	O
mean	O
age	O
of	O
patients	O
was	O
67.3	O
±	O
0.05	O
(	O
Mean	O
±	O
SEM	O
)	O
years	O
at	O
the	O
start	O
of	O
the	O
observation	O
,	O
2	O
were	O
African	O
Americans	O
and	O
one	O
was	O
Hispanic	O
,	O
6	F-NUM
patients	O
were	O
women	O
and	O
7	O
had	O
type	O
II	O
diabetes	O
mellitus	O
.	O

MATERIALS	O
AND	O
METHODSPatientsA	O
total	O
of	O
69	O
patients	O
(	O
16	M-NUM
males	O
,	O
53	F-NUM
females	O
;	O
mean	O
age	O
42.3	O
±16.2	O
years	O
)	O
,	O
affected	O
by	O
AICU	O
,	O
living	O
in	O
North-East	O
Italy	O
,	O
wereselected	O
from	O
the	O
outpatient	O
clinic	O
of	O
the	O
Dipartimento	O
diMedicina	O
Clinica	O
,	O
Università	O
di	O
Verona	O
(	O
Italy	O
)	O
.	O

The	O
control	O
group	O
wasrepresented	O
by	O
200	O
healthy	O
subjects	O
,	O
enrolled	O
in	O
the	O
bone	O
marrowdonors	O
register	O
(	O
97	M-NUM
males	O
,	O
103	F-NUM
females	O
;	O
mean	O
age	O
29.9	O
±	O
4.9years	O
)	O
,	O
from	O
the	O
same	O
geographic	O
region	O
,	O
sex-	O
and	O
age-matched	O
.	O

Materials	O
and	O
MethodsStudy	O
subjectsSubjects	O
were	O
recruited	O
between	O
May	O
1997	O
and	O
July	O
1999	O
from	O
2,273	O
women	O
approached	O
during	O
prenatal	O
visits	O
at	O
one	O
of	O
three	O
clinics	O
of	O
the	O
Mexican	O
Institute	O
of	O
Social	O
Security	O
(	O
IMSS	O
)	O
in	O
Mexico	O
City	O
.	O

A	O
total	O
of	O
280	F-NUM
already	O
pregnant	O
women	O
were	O
recruited	O
;	O
182	O
women	O
with	O
a	O
negative	O
pregnancy	O
test	O
declared	O
an	O
intention	O
to	O
become	O
pregnant	O
in	O
the	O
near	O
future	O
and	O
were	O
also	O
recruited	O
.	O

Gender	O
was	O
assigned	O
a	O
value	O
of	O
1	M-NUM
for	O
male	O
and	O
0	F-NUM
for	O
female	O
.	O

MethodsWe	O
measured	O
cervical	O
impedance	O
in	O
12	F-NUM
healthy	O
women	O
undergoing	O
pregnancy	O
termination	O
during	O
the	O
first	O
trimester	O
.	O

SubjectsFor	O
this	O
study	O
29	O
patients	O
(	O
6	M-NUM
males	O
,	O
23	F-NUM
females	O
;	O
mean	O
age	O
48	O
±	O
11.3	O
(	O
SD	O
)	O
years	O
)	O
with	O
CRPS1	O
in	O
one	O
hand	O
according	O
to	O
the	O
criteria	O
of	O
Bruehl	O
[	O
3	O
]	O
,	O
were	O
included	O
.	O

32.8	O
(	O
±	O
8.6	O
)	O
years	O
and	O
31.9	O
(	O
±	O
10.2	O
)	O
years	O
,	O
respectively	O
)	O
and	O
gender-distribution	O
(	O
11	F-NUM
females	O
in	O
YG	O
group	O
and	O
13	O
in	O
WL	O
group	O
)	O
.Both	O
groups	O
were	O
assessed	O
at	O
baseline	O
and	O
after	O
60	O
days	O
.	O

Twelve	O
healthy	O
controls	O
(	O
1	M-NUM
male	O
;	O
11	F-NUM
female	O
;	O
mean	O
age	O
43.8	O
y	O
;	O
SD	O
9.5	O
)	O
were	O
included	O
in	O
the	O
study	O
.	O

This	O
recruitment	O
procedure	O
resulted	O
in	O
an	O
overall	O
response	O
rate	O
of	O
79.4	O
%	O
.Sample	O
CharacteristicsThe	O
sample	O
for	O
this	O
analysis	O
is	O
made	O
up	O
individuals	O
from	O
the	O
U.S.	O
reservations	O
only	O
and	O
consisted	O
of	O
865	O
parents/caretakers	O
(	O
264	M-NUM
males	O
and	O
601	F-NUM
females	O
)	O
of	O
tribally	O
enrolled	O
children	O
aged	O
10–12	O
years	O
.	O

Gender	O
is	O
a	O
dummy	O
variable	O
coded	O
as	O
male	O
=	O
0	O
and	O
female	O
=	O
1	O
.	O

Material	O
and	O
MethodsPatientsSamples	O
from	O
peripheral	O
blood	O
(	O
PB	O
)	O
were	O
obtained	O
from	O
50	M-NUM
male	O
patients	O
affected	O
by	O
solid	O
tumors	O
and	O
50	O
healthy	O
controls	O
,	O
matched	O
for	O
age	O
and	O
sex	O
.	O

A	O
pool	O
of	O
peripheral-blood-derived	O
DNA	O
from	O
10	F-NUM
normal	O
females	O
was	O
used	O
as	O
normal	O
reference	O
DNA	O
for	O
all	O
hybridizations	O
performed	O
.	O

A	O
random	O
sample	O
of	O
200	F-NUM
women	O
was	O
taken	O
from	O
the	O
Greenland	O
statistics	O
list	O
comprising	O
547	O
eligible	O
women	O
.	O

Of	O
the	O
200	F-NUM
women	O
,	O
7	O
had	O
died	O
,	O
11	O
had	O
moved	O
to	O
another	O
town	O
and	O
15	O
were	O
out	O
of	O
town	O
at	O
the	O
time	O
of	O
the	O
study	O
(	O
not	O
for	O
medical	O
reasons	O
)	O
.	O

Thus	O
,	O
167	F-NUM
women	O
were	O
invited	O
to	O
participate	O
to	O
the	O
study	O
;	O
eight	O
declined	O
,	O
for	O
a	O
participation	O
rate	O
of	O
95	O
%	O
.	O

Community	O
leaders	O
invited	O
approximately	O
35	F-NUM
women	O
identified	O
as	O
home	O
caregivers	O
from	O
each	O
neighborhood	O
.	O

The	O
control	O
population	O
consisted	O
of	O
21	O
healthy	O
individuals	O
(	O
10	F-NUM
female	O
and	O
11	M-NUM
male	O
,	O
mean	O
age	O
31.8	O
±	O
1.7	O
years	O
)	O
.AntigensRecombinant	O
full-length	O
hnRNP-A2	O
was	O
used	O
in	O
all	O
experiments	O
.	O

The	O
average	O
age	O
was	O
67.5	O
±	O
8.9	O
years	O
old	O
and	O
the	O
study	O
included	O
3	M-NUM
males	O
and	O
5	F-NUM
females	O
.	O

In	O
one	O
case	O
(	O
male	O
,	O
49	O
years	O
old	O
)	O
,	O
we	O
obtained	O
cartilage	O
explants	O
from	O
a	O
patient	O
who	O
had	O
undergone	O
limb	O
amputation	O
due	O
to	O
a	O
road	O
traffic	O
accident	O
and	O
was	O
free	O
from	O
OA	O
.	O

For	O
example	O
,	O
a	O
largetrial	O
performed	O
on	O
305	F-NUM
women	O
has	O
shown	O
spontaneous	O
ovulation	O
inover	O
50	O
%	O
of	O
the	O
time	O
(	O
600	O
mg	O
troglitazone	O
)	O
in	O
comparisonwith	O
approximately	O
10	O
%	O
of	O
placebo	O
group	O
[	O
33	O
]	O
.	O

A	O
total	O
of	O
11	M-NUM
healthy	O
men	O
and	O
21	F-NUM
women	O
(	O
ave	O
age	O
30	O
±	O
8	O
y	O
)	O
were	O
initially	O
recruited	O
by	O
advertisement	O
among	O
the	O
450	O
staff	O
members	O
at	O
the	O
research	O
facilities	O
of	O
the	O
Palm	O
Oil	O
Board	O
.	O

A	O
total	O
of	O
279	F-NUM
postmenopausal	O
women	O
with	O
type	O
2	O
diabetes	O
,	O
who	O
were	O
patients	O
of	O
participating	O
primary	O
care	O
clinics	O
,	O
were	O
recruited	O
for	O
the	O
study	O
.	O

When	O
the	O
Pvalue	O
was	O
below	O
0.05	O
,	O
we	O
considered	O
the	O
deviation	O
of	O
equal	O
EST	O
distribution	O
among	O
salivary	O
and	O
remaining	O
libraries	O
as	O
significant.RT-PCR	O
expression	O
analysisFor	O
RT-PCR	O
analysis	O
,	O
SG	O
were	O
dissected	O
from	O
adult	O
females	O
1	O
to	O
5	O
days	O
after	O
emergence	O
and	O
stored	O
at	O
-80°C	O
.	O

The	O
patients	O
were	O
14	M-NUM
males	O
and	O
eight	O
females	O
,	O
with	O
a	O
mean	O
age	O
of	O
25	O
years	O
(	O
range	O
8	O
to	O
62	O
years	O
)	O
.	O

Included	O
were	O
15	F-NUM
women	O
and	O
6	M-NUM
men	O
,	O
ages	O
40	O
to	O
66	O
years	O
(	O
mean	O
=	O
51	O
;	O
SD	O
=	O
9	O
)	O
.	O

MethodsSnap	O
frozen	O
tissue	O
samples	O
were	O
obtained	O
for	O
immunoblot	O
analysis	O
from	O
17	O
patients	O
undergoing	O
resections	O
for	O
gastric	O
tumors	O
(	O
3	O
MALT	O
and	O
14	O
adenocarcinomas	O
from	O
5	F-NUM
female	O
and	O
12	M-NUM
male	O
patients	O
;	O
average	O
age	O
:	O
62	O
)	O
.	O

A	O
total	O
of	O
40	O
patients	O
(	O
aged	O
70.8	O
±	O
7.9	O
years	O
(	O
mean	O
±	O
standard	O
deviation	O
(	O
SD	O
)	O
)	O
;	O
18	M-NUM
males	O
,	O
22	F-NUM
females	O
)	O
classified	O
as	O
having	O
OA	O
according	O
to	O
recognized	O
American	O
College	O
of	O
Rheumatology	O
clinical	O
criteria	O
were	O
included	O
in	O
this	O
study	O
[	O
21	O
]	O
.	O

A	O
total	O
of	O
16	O
bone	O
specimens	O
of	O
medial	O
tibial	O
plateaus	O
from	O
normal	O
individuals	O
(	O
aged	O
61.5	O
±	O
15.6	O
years	O
(	O
mean	O
±	O
SD	O
)	O
;	O
9	M-NUM
males	O
,	O
7	F-NUM
females	O
)	O
were	O
collected	O
at	O
autopsy	O
within	O
12	O
h	O
of	O
death	O
.	O

A	O
total	O
of	O
35	O
patients	O
(	O
aged	O
68.8	O
±	O
7.6	O
years	O
(	O
mean	O
±	O
SD	O
)	O
;	O
7	M-NUM
males	O
,	O
28	F-NUM
females	O
)	O
classified	O
as	O
having	O
OA	O
,	O
as	O
defined	O
in	O
the	O
recognized	O
clinical	O
criteria	O
of	O
the	O
American	O
College	O
of	O
Rheumatology	O
,	O
were	O
included	O
in	O
this	O
study	O
[	O
36	O
]	O
.	O

A	O
total	O
of	O
18	O
subchondral	O
bone	O
specimens	O
of	O
tibial	O
plateaux	O
from	O
normal	O
individuals	O
(	O
aged	O
62.2	O
±	O
14.3	O
years	O
(	O
mean	O
±	O
SD	O
)	O
;	O
11	M-NUM
males	O
,	O
7	F-NUM
females	O
)	O
were	O
collected	O
at	O
autopsy	O
within	O
16	O
hours	O
of	O
death	O
.	O

A	O
total	O
of	O
762	O
and	O
341	F-NUM
women	O
were	O
sampled	O
from	O
Michalovce	O
and	O
Svidnik/Stropkov	O
,	O
respectively	O
.	O

Materials	O
and	O
MethodsPopulationThe	O
POUCH	O
Study	O
recruited	O
women	O
from	O
52	O
participating	O
prenatal	O
clinics	O
located	O
in	O
five	O
Michigan	O
communities	O
,	O
each	O
of	O
which	O
include	O
urban	O
,	O
suburban	O
,	O
and	O
rural	O
areas	O
(	O
Holzman	O
et	O
al	O
.	O

MethodsStudy	O
populationsAs	O
healthy	O
controls	O
,	O
276	O
non-diabetic	O
subjects	O
(	O
110	M-NUM
males	O
and	O
166	F-NUM
females	O
)	O
without	O
any	O
history	O
of	O
chronic	O
inflammatory	O
bowel	O
diseases	O
were	O
included	O
in	O
the	O
study	O
.	O

MethodsSubjectsTwenty	O
healthy	O
subjects	O
(	O
6	F-NUM
females	O
and	O
fourteen	O
males	O
,	O
weight	O
range	O
:	O
55–86	O
kg	O
,	O
mean	O
BMI	O
22.5	O
±	O
2	O
kg/m2	O
,	O
mean	O
age	O
22.2	O
±	O
0.5	O
years	O
)	O
participated	O
in	O
the	O
study	O
.	O

Heart	O
failure	O
patients	O
were	O
in	O
NYHA	O
class	O
III–IV	O
(	O
17–63	O
y	O
,	O
3	F-NUM
females	O
)	O
mean	O
duration	O
of	O
symptomatic	O
heart	O
failure	O
ranged	O
from	O
9–60	O
months	O
,	O
peak	O
oxygen	O
exercise	O
capacity	O
was	O
13.3–15.5	O
ml	O
kg−1	O
min−1	O
at	O
time	O
of	O
listing	O
.	O

The	O
study	O
was	O
conducted	O
on	O
31	O
common	O
or	O
internal	O
carotid	O
artery	O
plaques	O
from	O
the	O
31	O
remaining	O
patients	O
(	O
22	M-NUM
men	O
and	O
9	F-NUM
women	O
;	O
mean	O
age	O
68.03	O
±	O
7.3	O
years	O
)	O
.	O

Materials	O
and	O
methodsForty	O
consecutive	O
patients	O
(	O
mean	O
age	O
54	O
year	O
,	O
28	M-NUM
males	O
and	O
12	F-NUM
females	O
)	O
undergoing	O
resection	O
of	O
early	O
(	O
T	O
stage	O
I/II	O
)	O
oral	O
squamous	O
cell	O
carcinoma	O
at	O
the	O
department	O
of	O
Head	O
&	O
Neck	O
Surgery	O
,	O
University	O
College	O
London	O
Hospitals	O
,	O
were	O
recruited	O
for	O
this	O
trial	O
.	O

Material	O
and	O
MethodsSubjectsFourteen	O
subjects	O
(	O
9	F-NUM
females	O
,	O
5	M-NUM
males	O
,	O
mean	O
age	O
=	O
23.7	O
years	O
,	O
range	O
=	O
20–34	O
years	O
)	O
without	O
professional	O
musical	O
education	O
participated	O
in	O
this	O
study	O
after	O
giving	O
written	O
informed	O
consent	O
.	O

The	O
town	O
has	O
a	O
population	O
of	O
21,000	O
inhabitants	O
,	O
including	O
7,150	O
men	O
>	O
19	O
years	O
if	O
age	O
.	O

Men	O
aged	O
19–50	O
were	O
examined	O
once	O
,	O
whereas	O
790	M-NUM
men	O
aged	O
50–85	O
were	O
followed	O
up	O
prospectively	O
for	O
90	O
months	O
.	O

MethodsSubjectsNormal	O
subjects	O
(	O
443	F-NUM
females	O
and	O
292	M-NUM
males	O
)	O
were	O
evaluated	O
following	O
informed	O
consent	O
under	O
a	O
human	O
research	O
protocol	O
approved	O
by	O
the	O
IRB	O
.	O

The	O
focus	O
group	O
was	O
40	F-NUM
%	O
female	O
,	O
all	O
were	O
aged	O
25–44	O
,	O
and	O
a	O
third	O
had	O
participated	O
in	O
HIV	O
trials	O
.	O

Individuals	O
registered	O
at	O
PACT	O
are	O
recruited	O
into	O
ongoing	O
trials	O
at	O
the	O
ACTU.In	O
December	O
2002	O
,	O
897	O
patients	O
were	O
registered	O
at	O
PACT	O
;	O
679	M-NUM
(	O
76	O
%	O
)	O
were	O
men	O
,	O
597	O
(	O
66	O
%	O
)	O
were	O
white	O
,	O
and	O
286	O
(	O
32	O
%	O
)	O
were	O
African-American	O
.	O

Materials	O
and	O
MethodsParticipantsA	O
total	O
of	O
26	O
healthy	O
right-handed	O
subjects	O
between	O
the	O
ages	O
of	O
18	O
and	O
30	O
were	O
assigned	O
to	O
either	O
a	O
nap	O
group	O
(	O
n	O
=	O
14	O
;	O
7	M-NUM
males	O
,	O
mean	O
age	O
24.3	O
[	O
S.D.±2.0	O
]	O
)	O
or	O
no-nap	O
group	O
(	O
n	O
=	O
12	O
,	O
8	O
males	O
,	O
mean	O
age	O
23.1	O
[	O
S.D.±1.4	O
]	O
)	O
.	O

Materials	O
and	O
methodsTissue	O
collectionBiopsies	O
of	O
human	O
myometrium	O
were	O
obtained	O
from	O
26	F-NUM
women	O
undergoing	O
elective	O
cesarean	O
section	O
in	O
the	O
third	O
trimester	O
of	O
pregnancy	O
,	O
in	O
the	O
Department	O
of	O
Obstetrics	O
and	O
Gynecology	O
,	O
University	O
College	O
Hospital	O
,	O
Galway	O
,	O
Ireland	O
.	O

MethodsClinical	O
assessmentWe	O
studied	O
a	O
total	O
of	O
22	F-NUM
female	O
subjects	O
:	O
16	O
were	O
patients	O
with	O
various	O
forms	O
of	O
lipodystrophy	O
and	O
6	O
were	O
normal	O
healthy	O
controls	O
,	O
with	O
normal	O
fat	O
distribution	O
clinically	O
and	O
absence	O
of	O
mutations	O
in	O
known	O
lipodystrophy	O
genes	O
.	O

Similarly	O
morphologically	O
normal	O
tissues	O
were	O
used	O
for	O
epididymal	O
sections	O
from	O
a	O
56	O
year-old	O
male	O
(	O
Subject	O
#	O
5	O
)	O
,	O
and	O
the	O
slides	O
were	O
obtained	O
from	O
the	O
histology	O
core	O
at	O
the	O
University	O
of	O
North	O
Carolina	O
Medical	O
School	O
.	O

Macaque	O
(	O
cynomolgus	O
)	O
reproductive	O
issues	O
were	O
obtained	O
from	O
Covance	O
(	O
Alice	O
,	O
TX	O
)	O
from	O
two	O
2	M-NUM
males	O
who	O
were	O
5	O
years	O
old	O
and	O
of	O
known	O
fertility	O
.	O

Ten	O
healthy	O
,	O
unimpaired	O
subjects	O
(	O
7	M-NUM
male	O
,	O
23–39	O
yrs	O
)	O
completed	O
three	O
experiments	O
during	O
which	O
a	O
lightweight	O
,	O
two	O
degrees-of-freedom	O
,	O
planar	O
robot	O
(	O
Fig	O
.	O

Fifty-one	O
DL	O
specimens	O
were	O
available	O
for	O
methylation	O
pattern	O
analysis	O
from	O
24	F-NUM
women	O
,	O
of	O
whom	O
19	O
were	O
BRCA	O
mutation	O
carriers	O
(	O
7	O
BRCA1	O
and	O
12	O
BRCA2	O
)	O
and	O
5	O
were	O
negative	O
controls	O
on	O
the	O
basis	O
of	O
the	O
predictive	O
genetic	O
test	O
.	O

To	O
detect	O
this	O
10	O
%	O
difference	O
in	O
sick	O
leave	O
,	O
a	O
minimum	O
of	O
275	F-NUM
women	O
is	O
required	O
per	O
group	O
.	O

A	O
total	O
of	O
at	O
least	O
550	F-NUM
women	O
is	O
needed	O
for	O
the	O
entire	O
study.AnalysisFor	O
the	O
RCT	O
,	O
data	O
will	O
be	O
analysed	O
using	O
statistical	O
tests	O
such	O
as	O
linear	O
regression	O
analysis	O
and	O
Cox	O
regression	O
analysis	O
.	O

In	O
total	O
,	O
204	O
informative	O
meiosis	O
(	O
83	F-NUM
female	O
,	O
98	M-NUM
male	O
,	O
and	O
23	O
of	O
unknown	O
sex	O
)	O
were	O
typed	O
with	O
62	O
different	O
microsatellite	O
polymorphic	O
markers	O
(	O
see	O
Additional	O
file	O
1	O
)	O
over	O
a	O
region	O
spanning	O
6,5	O
Mb	O
.	O

As	O
an	O
exception	O
,	O
3	O
breakpoints	O
were	O
localized	O
to	O
LCR22-2	O
(	O
2	M-NUM
male	O
and	O
1	F-NUM
female	O
)	O
and	O
1	O
breakpoint	O
to	O
LCR22-4	O
(	O
male	O
)	O
.	O

The	O
specimens	O
were	O
obtained	O
from	O
16	M-NUM
males	O
and	O
11	F-NUM
females	O
ranging	O
between	O
43	O
and	O
79	O
years	O
of	O
age	O
(	O
mean	O
age	O
of	O
63.6	O
years	O
)	O
.	O

METHODSParticipantsA	O
total	O
of	O
81	O
overweight	O
adult	O
men	O
and	O
women	O
were	O
enrolled	O
in	O
the	O
study	O
.	O

Specific	O
criteria	O
for	O
inclusion	O
were	O
age	O
between	O
40	O
and	O
75	O
years	O
,	O
BMI	O
≥	O
27	O
kg/m2	O
,	O
and	O
WC	O
>	O
100	O
cm	O
for	O
men	O
and	O
>	O
88	O
cm	O
for	O
women	O
.	O

Ninety-five	O
of	O
the	O
157	F-NUM
women	O
randomised	O
to	O
the	O
ACHOIS	O
trial	O
at	O
the	O
WCH	O
gave	O
written	O
informed	O
consent	O
to	O
participate	O
in	O
this	O
study	O
and	O
cord	O
blood	O
samples	O
were	O
able	O
to	O
be	O
collected	O
during	O
the	O
study	O
period	O
.	O

Forty-six	O
women	O
had	O
been	O
randomised	O
to	O
the	O
Treatment	O
Group	O
and	O
received	O
dietary	O
advice	O
,	O
blood	O
glucose	O
monitoring	O
and	O
insulin	O
as	O
necessary	O
as	O
recommended	O
by	O
clinical	O
practice	O
guidelines	O
[	O
18	O
]	O
,	O
and	O
49	F-NUM
women	O
had	O
been	O
randomised	O
to	O
the	O
Routine	O
Care	O
group	O
and	O
received	O
routine	O
pregnancy	O
care	O
.	O

A	O
Control	O
group	O
of	O
133	F-NUM
women	O
with	O
a	O
normal	O
OGTT	O
was	O
also	O
recruited	O
from	O
the	O
WCH	O
during	O
the	O
time	O
course	O
of	O
this	O
study	O
and	O
gave	O
written	O
informed	O
consent	O
to	O
participate	O
.	O

Data	O
and	O
specimens	O
were	O
obtained	O
from	O
593	F-NUM
women	O
,	O
517	O
of	O
whom	O
provided	O
blood	O
and	O
76	O
,	O
buccal	O
cells	O
.	O

Materials	O
and	O
MethodsRNA	O
preparationOne	O
whole	O
human	O
brain	O
from	O
a	O
36	O
year	O
old	O
male	O
was	O
flash	O
frozen	O
in	O
liquid	O
nitrogen	O
approximately	O
18	O
hours	O
postmortem	O
.	O

Although	O
it	O
is	O
well	O
known	O
that	O
estrogens	O
induce	O
100	F-NUM
%	O
females	O
in	O
X.	O
laevis	O
(	O
Chang	O
and	O
Witschi	O
1955	O
;	O
Gallien	O
1953	O
;	O
Hayes	O
1998	O
)	O
,	O
the	O
concentration	O
and	O
timing	O
of	O
exposure	O
are	O
important	O
for	O
complete	O
sex	O
reversal	O
of	O
all	O
exposed	O
individuals	O
.	O

As	O
a	O
result	O
,	O
374	O
colorectal	O
cancer	O
cases	O
(	O
174	M-NUM
from	O
the	O
men	O
's	O
cohort	O
and	O
200	F-NUM
from	O
the	O
women	O
's	O
cohort	O
)	O
were	O
further	O
studied	O
.	O

Detailed	O
methods	O
have	O
been	O
published	O
elsewhere	O
(	O
NCHS	O
2006b	O
)	O
.We	O
limited	O
our	O
analysis	O
to	O
men	O
>	O
18	O
years	O
of	O
age	O
with	O
complete	O
data	O
for	O
the	O
measures	O
described	O
below	O
.	O

The	O
study	O
consisted	O
of	O
10	O
volunteers	O
(	O
5	F-NUM
females	O
and	O
5	O
males	O
)	O
recruited	O
for	O
this	O
study	O
.	O

Control	O
nerves	O
(	O
n	O
=	O
8	O
;	O
male	O
6	M-NUM
;	O
age	O
range	O
36	O
–	O
81	O
y	O
)	O
were	O
obtained	O
during	O
routine	O
surgery	O
for	O
limb	O
amputation	O
or	O
similar	O
procedures	O
,	O
and	O
control	O
DRG	O
(	O
n	O
=	O
8	O
;	O
male	O
3	O
;	O
age	O
range	O
41	O
–	O
98	O
yr	O
)	O
obtained	O
via	O
the	O
Netherlands	O
Brain	O
Bank	O
with	O
less	O
than	O
12	O
h	O
post-mortem	O
delay	O
.	O

Dorsal	O
and	O
ventral	O
pairs	O
of	O
injured	O
(	O
root	O
avulsion	O
)	O
spinal	O
nerve	O
roots	O
were	O
obtained	O
also	O
during	O
brachial	O
plexus	O
repair	O
(	O
n	O
=	O
9	O
,	O
4	O
acute	O
and	O
5	O
chronic	O
;	O
male	O
8	O
;	O
age	O
range	O
22	O
–	O
47	O
y	O
)	O
.	O

Neuropathic	O
,	O
sural	O
nerve	O
biopsies	O
(	O
n	O
=	O
6	O
;	O
4	M-NUM
male	O
;	O
age	O
range	O
49	O
–	O
71	O
yr	O
)	O
were	O
obtained	O
from	O
patients	O
with	O
neuropathies	O
,	O
including	O
demyelinating	O
and	O
polyneuropathies	O
.	O

Control	O
,	O
human	O
spinal	O
cords	O
(	O
n	O
=	O
2	O
;	O
male	O
1	M-NUM
;	O
age	O
60	O
and	O
64	O
y	O
)	O
,	O
with	O
small	O
attached	O
nerve	O
roots	O
,	O
were	O
obtained	O
after	O
less	O
than	O
12	O
h	O
post-mortem	O
delay	O
via	O
the	O
Netherlands	O
Brain	O
Bank	O
.	O

Normal	O
,	O
hyper-	O
and	O
hypo-sensitive	O
skin	O
and	O
painful	O
neuroma	O
samples	O
were	O
collected	O
from	O
the	O
amputated	O
arm	O
of	O
a	O
patient	O
who	O
had	O
a	O
brachial	O
plexus	O
injury	O
with	O
subsequent	O
repair	O
8	O
years	O
previously	O
(	O
n	O
=	O
1	M-NUM
;	O
male	O
,	O
age	O
46	O
y	O
)	O
;	O
.	O

The	O
mean	O
age	O
of	O
the	O
seven	O
females	O
was	O
29	O
years	O
and	O
for	O
the	O
three	O
males	O
was	O
30	O
years	O
.	O

MethodsStudy	O
designTwenty-two	O
patients	O
with	O
moderate	O
to	O
severe	O
psoriasis	O
(	O
19	M-NUM
males	O
,	O
3	F-NUM
females	O
,	O
ages	O
29–68	O
years	O
,	O
median	O
49	O
years	O
)	O
were	O
enrolled	O
in	O
this	O
study	O
,	O
which	O
was	O
approved	O
by	O
The	O
Rockefeller	O
University	O
Hospital	O
Institutional	O
Review	O
Board	O
,	O
and	O
completed	O
in	O
2003	O
.	O

The	O
mean	O
age	O
of	O
the	O
RA	O
patients	O
(	O
9	F-NUM
females	O
and	O
1	M-NUM
male	O
)	O
was	O
48.3	O
years	O
.	O

Osteoarthritis	O
(	O
OA	O
)	O
FLSs	O
,	O
isolated	O
from	O
5	F-NUM
female	O
OA	O
patients	O
(	O
mean	O
age	O
66.2	O
years	O
)	O
,	O
were	O
used	O
as	O
a	O
control	O
.	O

The	O
actual	O
sample	O
recruited	O
was	O
340	F-NUM
unmarried	O
women	O
in	O
the	O
intervention	O
group	O
and	O
258	O
in	O
the	O
control	O
group.InterventionThe	O
intervention	O
was	O
designed	O
to	O
promote	O
use	O
of	O
effective	O
contraceptives	O
among	O
unmarried	O
female	O
migrant	O
factory	O
workers	O
(	O
aged	O
16–30	O
years	O
)	O
.	O

MethodsLung	O
cancer	O
tissuesTumor	O
samples	O
were	O
obtained	O
from	O
42	O
patients	O
(	O
31	M-NUM
males	O
,	O
11	F-NUM
females	O
)	O
undergoing	O
lobe-	O
or	O
pneumectomy	O
because	O
of	O
lung	O
cancer	O
,	O
their	O
age	O
ranging	O
between	O
43	O
and	O
78	O
years	O
.	O

MethodsSubjectsNon-smoking	O
males	O
and	O
females	O
between	O
18	O
and	O
30	O
years	O
of	O
age	O
were	O
recruited	O
for	O
participation	O
at	O
Maastricht	O
University	O
,	O
The	O
Netherlands	O
,	O
by	O
way	O
of	O
information	O
pamphlets	O
.	O

The	O
baseline	O
questionnaire	O
provided	O
a	O
list	O
of	O
238	F-NUM
women	O
(	O
115	O
control	O
,	O
123	O
intervention	O
)	O
,	O
among	O
whom	O
208	O
(	O
104	O
control	O
,	O
104	O
intervention	O
)	O
were	O
living	O
and	O
found	O
at	O
home	O
during	O
the	O
substudy	O
recruitment	O
visit	O
.	O

Among	O
the	O
185	F-NUM
eligible	O
women	O
invited	O
to	O
participate	O
,	O
the	O
response	O
rates	O
were	O
75	O
%	O
among	O
the	O
control	O
households	O
and	O
54	O
%	O
among	O
the	O
intervention	O
households	O
,	O
resulting	O
in	O
120	O
(	O
71	O
control	O
,	O
49	O
intervention	O
)	O
participants	O
overall	O
.	O

The	O
trial	O
period	O
,	O
from	O
July	O
2003	O
through	O
December	O
2005	O
,	O
included	O
111	O
measures	O
among	O
71	F-NUM
women	O
in	O
the	O
control	O
group	O
cooking	O
over	O
open	O
fires	O
and	O
115	O
measures	O
among	O
49	O
women	O
in	O
the	O
intervention	O
group	O
using	O
the	O
improved	O
stoves	O
.	O

MethodsTwelve	O
human	O
subjects	O
(	O
11	F-NUM
females	O
,	O
1	M-NUM
male	O
;	O
age	O
range	O
24–74	O
)	O
were	O
recruited	O
and	O
signed	O
informed	O
consent	O
for	O
this	O
study	O
.	O

Two	O
subjects	O
were	O
patients	O
undergoing	O
spinal	O
fusion	O
surgery	O
(	O
one	O
74	O
year	O
old	O
female	O
and	O
one	O
47	O
year	O
old	O
female	O
)	O
.	O

The	O
eight	O
women	O
and	O
10	M-NUM
men	O
who	O
agreed	O
to	O
participate	O
in	O
the	O
study	O
ranged	O
in	O
age	O
from	O
their	O
20s	O
to	O
their	O
50s	O
.	O

MethodsGenomic	O
DNABlood	O
samples	O
were	O
obtained	O
from	O
10	F-NUM
healthy	O
male	O
and	O
10	O
female	O
Japanese	O
volunteers	O
with	O
informed	O
consent	O
.	O

The	O
men	O
received	O
alendronate	O
10	O
mg	O
daily	O
(	O
28	F-NUM
men	O
)	O
,	O
PTH	O
40	O
μg	O
subcutaneously	O
(	O
27	M-NUM
men	O
)	O
,	O
or	O
both	O
(	O
28	O
men	O
)	O
.	O

The	O
study	O
suggested	O
that	O
alendronate	O
significantly	O
impairs	O
the	O
anabolic	O
effect	O
of	O
teriparatide	O
,	O
especially	O
if	O
patients	O
have	O
been	O
pre-treated	O
with	O
alendronate.Black	O
et	O
al	O
(	O
2003	O
)	O
conducted	O
a	O
similar	O
study	O
in	O
238	F-NUM
women	O
with	O
a	O
T-score	O
of	O
less	O
than	O
−2.5	O
for	O
BMD	O
at	O
the	O
femoral	O
neck	O
,	O
total	O
hip	O
,	O
or	O
spine	O
.	O

However	O
,	O
insulin	O
levels	O
were	O
44	O
%	O
higher	O
in	O
overweight/obese	O
women	O
at	O
7	O
days	O
(	O
non-fasting	O
levels	O
and	O
inadequate	O
power	O
)	O
.Path	O
analysis	O
:	O
effect	O
of	O
pre-pregnant	O
BMI	O
on	O
prolactin	O
response	O
at	O
7	O
days	O
:	O
-30.9	O
ng/ml.The	O
final	O
table	O
(	O
Table	O
4	O
.	O

The	O
average	O
age	O
(	O
mean	O
±	O
SE	O
)	O
was	O
50	O
±	O
1	O
years	O
for	O
females	O
,	O
and	O
56	O
±	O
4	O
years	O
for	O
males	O
.	O

PatientsThis	O
study	O
comprised	O
transplant	O
biopsy	O
specimens	O
from	O
15	O
patients	O
(	O
66	M-PER
%	O
of	O
men	O
with	O
mean	O
age	O
of	O
47	O
±	O
15	O
years	O
)	O
.	O

MethodsA	O
total	O
of	O
twenty-one	O
healthy	O
women	O
aged	O
21	O
–	O
38	O
years	O
(	O
28.4	O
±	O
5.4	O
years	O
,	O
mean	O
±	O
SD	O
)	O
were	O
studied	O
during	O
the	O
years	O
2002	O
and	O
2003	O
in	O
a	O
randomized	O
,	O
double	O
blind	O
,	O
placebo-controlled	O
trial	O
of	O
recombinant	O
human	O
prolactin	O
administration	O
(	O
r-hPRL	O
;	O
Genzyme	O
Corporation	O
,	O
Cambridge	O
,	O
MA	O
[	O
31	O
]	O
)	O
.	O

A	O
z	O
-test	O
was	O
used	O
to	O
determine	O
whether	O
the	O
rate	O
of	O
expressible	O
galactorrhea	O
exceeded	O
1	O
%	O
,	O
the	O
incidence	O
in	O
regularly	O
cycling	O
women	O
[	O
32	O
]	O
.	O

This	O
study	O
was	O
performed	O
four	O
times	O
within	O
few	O
weeks	O
of	O
interval.In	O
vivo	O
tumourigenesis	O
assaySixty	O
five	O
8	O
weeks-old	O
,	O
female	O
A/J	O
mice	O
,	O
were	O
purchased	O
from	O
Jackson	O
Laboratory	O
and	O
bred	O
under	O
standard	O
conditions	O
at	O
the	O
Experimental	O
Animal	O
Center	O
of	O
our	O
Research	O
center	O
.	O

MethodsSubjectsWe	O
enrolled	O
8	M-NUM
caucasic	O
male	O
healthy	O
non-smokers	O
,	O
non-obese	O
,	O
normo-cholesterol	O
,	O
normotensive	O
,	O
not	O
currently	O
under	O
pharmacological	O
treatment	O
volunteers	O
between	O
our	O
attendant	O
students	O
.	O

MethodsPatients	O
and	O
histological	O
samplesTotal	O
or	O
partial	O
mastectomy	O
specimens	O
obtained	O
from	O
52	F-NUM
women	O
,	O
who	O
were	O
clinically	O
and	O
histopathologically	O
diagnosed	O
of	O
breast	O
adenocarcinoma	O
during	O
1998	O
in	O
our	O
hospital	O
,	O
were	O
used	O
for	O
the	O
study	O
.	O

Seventeen	O
of	O
these	O
women	O
(	O
aged	O
from	O
37	O
to	O
75	O
years	O
;	O
mean	O
:	O
52.8	O
)	O
presented	O
in	O
situ	O
carcinoma	O
;	O
one	O
of	O
these	O
17	F-NUM
women	O
also	O
showed	O
lymph	O
node	O
infiltration	O
at	O
the	O
time	O
of	O
surgery	O
.	O

Thirty-five	O
women	O
(	O
aged	O
from	O
40	O
to	O
82	O
years	O
;	O
mean	O
:	O
59.94	O
)	O
had	O
infiltrating	O
carcinoma	O
;	O
13	O
of	O
these	O
35	F-NUM
women	O
showed	O
lymph	O
node	O
infiltration	O
at	O
the	O
time	O
of	O
surgery	O
,	O
and	O
7	O
of	O
these	O
13	O
developed	O
metastasis	O
7–24	O
months	O
after	O
surgery	O
.	O

In	O
December	O
1996	O
,	O
9864	M-NUM
men	O
over	O
the	O
age	O
of	O
50	O
had	O
been	O
screened	O
.	O

Inclusion	O
criteria	O
included	O
healthy	O
males	O
18	O
–	O
40	O
years	O
of	O
age	O
with	O
a	O
BMI	O
of	O
<	O
40	O
kg/m2	O
.	O

Materials	O
and	O
methodsPatientsTwenty-four	O
patients	O
(	O
9	F-NUM
females	O
,	O
15	M-NUM
males	O
)	O
with	O
a	O
mean	O
age	O
of	O
49±14	O
years	O
and	O
histopathologically	O
proven	O
tenascin	O
expression	O
of	O
malignant	O
gliomas	O
(	O
5	O
anaplastic	O
astrocytomas	O
,	O
19	O
glioblastomas	O
)	O
were	O
included	O
in	O
the	O
study	O
.	O

The	O
first	O
18	O
volunteers	O
were	O
stratified	O
into	O
males	O
and	O
females	O
and	O
then	O
randomized	O
by	O
two	O
blocks	O
of	O
9	O
(	O
1	O
block	O
=	O
females	O
,	O
1	O
block	O
=	O
males	O
)	O
in	O
3	O
groups	O
:	O
PEV301	O
10	O
µg	O
(	O
n	O
=	O
8	O
)	O
,	O
PEV302	O
10	O
µg	O
(	O
n	O
=	O
8	O
)	O
,	O
and	O
IRIVs	O
alone	O
(	O
control	O
;	O
n	O
=	O
2	O
)	O
.	O

Unless	O
otherwise	O
indicated	O
,	O
all	O
other	O
chemicals	O
were	O
purchased	O
from	O
Sigma	O
Chemical	O
Company.CellsHeparinized	O
peripheral	O
blood	O
samples	O
were	O
obtained	O
from	O
healthy	O
volunteers	O
(	O
9	M-NUM
men	O
and	O
7	F-NUM
women	O
ranging	O
in	O
age	O
from	O
22	O
to	O
55	O
years	O
without	O
medication	O
for	O
at	O
least	O
14	O
days	O
)	O
.	O

The	O
group	O
included	O
11	M-NUM
men	O
and	O
1	O
lefthander	O
.	O

Materials	O
and	O
MethodsExperiment	O
I	O
:	O
35	O
undergraduate	O
students	O
at	O
the	O
University	O
of	O
California	O
Davis	O
participated	O
in	O
the	O
study	O
(	O
age	O
range	O
18	O
to	O
22	O
;	O
18	O
females	O
)	O
.	O

After	O
5	O
generations	O
of	O
tumor	O
growth	O
doubling	O
the	O
xenografts	O
were	O
surgically	O
removed	O
from	O
the	O
mice	O
and	O
cut	O
into	O
approximately	O
4	O
mm3	O
portions	O
then	O
were	O
re-grafted	O
under	O
the	O
renal	O
capsules	O
of	O
6	M-NUM
male	O
Rag-2M	O
mice	O
(	O
4	O
grafts	O
per	O
mouse	O
,	O
2	O
per	O
kidney	O
)	O
.	O

Briefly	O
,	O
the	O
population	O
consisted	O
of	O
2,391	O
US	O
women	O
who	O
on	O
day	O
1	O
of	O
the	O
trial	O
were	O
16–23	O
years	O
of	O
age	O
,	O
and	O
did	O
not	O
report	O
a	O
history	O
of	O
pregnancy	O
,	O
abnormal	O
Pap	O
tests	O
or	O
more	O
than	O
5	O
lifetime	O
male	O
sex	O
partners	O
.	O

For	O
instance	O
,	O
among	O
63	F-NUM
women	O
with	O
an	O
incident	O
HPV-6	O
infection	O
followed	O
by	O
a	O
negative	O
swab	O
sample	O
,	O
and	O
at	O
least	O
one	O
additional	O
study	O
swab	O
,	O
only	O
2	O
(	O
3.2	O
%	O
)	O
had	O
a	O
non-negative	O
HPV-6	O
result	O
on	O
the	O
second	O
swab	O
or	O
a	O
concurrent	O
biopsy	O
specimen	O
.	O

No	O
persons	O
in	O
high	O
risk	O
groups	O
,	O
namely	O
people	O
under	O
18	O
years	O
or	O
women	O
of	O
reproductive	O
age	O
,	O
were	O
recruited	O
to	O
conduct	O
human	O
landing	O
catches	O
.	O

30	O
right-handed	O
human	O
participants	O
(	O
aged	O
18–43	O
y	O
,	O
mean	O
age	O
=	O
24.9	O
y	O
;	O
19	F-NUM
females	O
)	O
with	O
normal	O
hearing	O
and	O
no	O
history	O
of	O
audiological	O
or	O
neurological	O
disorders	O
provided	O
written	O
consent	O
prior	O
to	O
the	O
experiment	O
.	O

Eight	O
participants	O
had	O
to	O
be	O
excluded	O
due	O
to	O
excessive	O
head	O
movements	O
(	O
more	O
than	O
5	O
mm	O
translation	O
or	O
5°	O
rotation	O
within	O
one	O
session	O
)	O
or	O
not	O
meeting	O
the	O
psychophysical	O
assessment	O
criteria	O
(	O
see	O
below	O
)	O
,	O
leaving	O
a	O
total	O
of	O
22	O
participants	O
(	O
aged	O
18–40	O
y	O
,	O
mean	O
age	O
=	O
24.2	O
y	O
;	O
12	F-NUM
females	O
)	O
.Stimuli	O
.	O

30	O
right-handed	O
participants	O
(	O
aged	O
20–44	O
y	O
,	O
mean	O
age	O
=	O
28.0	O
y	O
;	O
16	F-NUM
females	O
)	O
with	O
normal	O
hearing	O
and	O
no	O
history	O
of	O
audiological	O
or	O
neurological	O
disorders	O
provided	O
written	O
consent	O
prior	O
to	O
the	O
experiment	O
.	O

Six	O
participants	O
had	O
to	O
be	O
excluded	O
because	O
of	O
excessive	O
head	O
movements	O
(	O
more	O
than	O
5-mm	O
translation	O
or	O
5°	O
rotation	O
within	O
one	O
session	O
)	O
,	O
leaving	O
a	O
total	O
of	O
24	O
participants	O
(	O
aged	O
20–44	O
y	O
,	O
mean	O
age	O
=	O
28.58	O
y	O
;	O
12	F-NUM
females	O
)	O
.Stimuli	O
.	O

IGF-I	O
concentration	O
amounted	O
to	O
86	O
nmol/l	O
(	O
normal	O
upper	O
level	O
for	O
her	O
age	O
32	O
nmol/l	O
)	O
Thyroid	O
and	O
adrenal	O
functions	O
were	O
normal	O
,	O
but	O
prolactin	O
concentration	O
was	O
elevated	O
to	O
20	O
μg/l	O
(	O
normal	O
upper	O
limit	O
for	O
females	O
12	O
μg/l	O
)	O
.	O

Thyroid	O
and	O
adrenal	O
functions	O
were	O
normal	O
,	O
but	O
prolactin	O
concentration	O
was	O
elevated	O
to	O
21	O
μg/l	O
(	O
normal	O
upper	O
limit	O
for	O
males	O
6	O
μg/l	O
)	O
.	O

Reference	O
values	O
were	O
obtained	O
in	O
nine	O
males	O
and	O
10	F-NUM
females	O
healthy	O
controls	O
.	O

As	O
indicator	O
of	O
overweight	O
,	O
a	O
percentage	O
body	O
fat	O
above	O
the	O
sex-specific	O
normal	O
range	O
(	O
male	O
>	O
19	M-PER
%	O
,	O
female	O
>	O
28	F-PER
%	O
)	O
was	O
taken	O
.	O

DNA	O
was	O
extracted	O
from	O
venous	O
blood	O
from	O
2201	O
individuals	O
(	O
939	M-NUM
males	O
,	O
1262	F-NUM
females	O
;	O
2115	O
Caucasian	O
,	O
72	O
African	O
American	O
,	O
6	O
Hispanic	O
,	O
3	O
Asian	O
,	O
5	O
Other	O
racial	O
origin	O
)	O
which	O
comprised	O
approximately	O
one-half	O
the	O
AREDS	O
participants	O
(	O
obtained	O
from	O
the	O
AREDS	O
Genetic	O
Repository	O
)	O
.	O

Forty-six	O
samples	O
were	O
from	O
females	O
and	O
64	M-NUM
were	O
from	O
males	O
.	O

The	O
study	O
subjects	O
consisted	O
of	O
32	F-NUM
pregnant	O
women	O
(	O
20–40	O
y	O
old	O
)	O
.	O

Blood	O
samples	O
were	O
collected	O
in	O
a	O
third	O
room.VolunteersAll	O
hand	O
rubs	O
were	O
tested	O
on	O
the	O
same	O
12	O
volunteers	O
(	O
6	F-NUM
male	O
,	O
6	O
female	O
)	O
.	O

Material	O
and	O
methodsSelection	O
of	O
patientsOur	O
study	O
group	O
consisted	O
of	O
19	O
patients	O
(	O
six	O
women	O
and	O
13	M-NUM
men	O
)	O
recently	O
treated	O
by	O
percutaneous	O
coronary	O
intervention	O
(	O
PCI	O
)	O
.	O

Therefore	O
,	O
we	O
took	O
medical	O
costs	O
from	O
a	O
study	O
due	O
to	O
Oster	O
et	O
al.	O
,	O
which	O
includes	O
obese	O
men	O
and	O
women	O
[	O
49	O
]	O
.	O

MethodsSubjectsWe	O
examined	O
formalin-fixed	O
,	O
paraffin-embedded	O
sections	O
from	O
post-mortem	O
samples	O
of	O
the	O
frontal	O
cortex	O
(	O
Brodmann	O
area	O
46	O
)	O
,	O
and	O
white	O
matter	O
and	O
basal	O
ganglia	O
from	O
25	O
cases	O
(	O
13	M-NUM
male	O
)	O
in	O
the	O
Oxford	O
Project	O
to	O
Investigate	O
Memory	O
and	O
Ageing	O
(	O
OPTIMA	O
)	O
.	O

MATERIALS	O
AND	O
METHODSPatients.47	O
patients	O
with	O
a	O
dermatologist-confirmed	O
diagnosis	O
of	O
chronic	O
plaque	O
psoriasis	O
(	O
25	F-NUM
female	O
and	O
22	M-NUM
male	O
;	O
age	O
range	O
,	O
18–58	O
yr	O
;	O
mean	O
age	O
,	O
40.9	O
yr	O
)	O
and	O
19	O
normal	O
healthy	O
volunteers	O
(	O
13	O
female	O
and	O
6	O
male	O
;	O
age	O
range	O
,	O
20–55	O
yr	O
;	O
mean	O
age	O
,	O
38.1	O
yr	O
)	O
were	O
recruited	O
for	O
study	O
.	O

An	O
additional	O
40	O
normal	O
volunteers	O
involved	O
in	O
previous	O
studies	O
(	O
24	F-NUM
female	O
and	O
20	M-NUM
male	O
;	O
age	O
range	O
,	O
19–56	O
yr	O
;	O
mean	O
age	O
,	O
35.7	O
yr	O
)	O
were	O
included	O
for	O
comparative	O
purposes	O
.	O

12	O
chimeras	O
were	O
generated	O
,	O
of	O
which	O
10	M-NUM
were	O
male	O
,	O
all	O
with	O
∼95	O
%	O
coat	O
color	O
chimerism	O
.	O

These	O
were	O
mated	O
to	O
DBA/C57	O
F1	O
females	O
;	O
6	O
produced	O
agouti	O
offspring	O
at	O
a	O
high	O
percentage	O
(	O
being	O
germline	O
transmission	O
of	O
the	O
mutated	O
ES	O
cells	O
)	O
.	O

Only	O
one	O
person	O
per	O
household	O
was	O
randomly	O
selected	O
and	O
a	O
total	O
of	O
3289	O
eligible	O
participants	O
(	O
1458	M-NUM
men	O
and	O
1831	F-NUM
women	O
)	O
were	O
finally	O
recruited	O
.	O

Cartilage	O
was	O
sampled	O
from	O
8	M-NUM
males	O
(	O
mean	O
age	O
,	O
68	O
yr	O
;	O
range	O
58–83	O
yr	O
)	O
and	O
17	F-NUM
females	O
(	O
mean	O
age	O
,	O
76	O
yr	O
;	O
range	O
37–93	O
yr	O
)	O
.	O

Polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
fragments	O
representing	O
9,908	O
kb	O
from	O
introns	O
3	O
and	O
4	O
were	O
sequenced	O
with	O
specific	O
primers	O
in	O
12	F-NUM
human	O
females	O
from	O
the	O
major	O
continental	O
populations	O
(	O
two	O
sub-Saharan	O
Africans	O
,	O
four	O
Europeans	O
,	O
three	O
Asians	O
,	O
and	O
three	O
Maghrebians	O
)	O
.	O

Each	O
exon	O
of	O
the	O
full-length	O
coding	O
region	O
of	O
SRPX2	O
was	O
amplified	O
by	O
PCR	O
and	O
sequenced	O
in	O
the	O
same	O
12	F-NUM
women	O
and	O
in	O
six	O
nonhuman	O
primate	O
species	O
,	O
using	O
inter-specific	O
consensus	O
intronic	O
primers	O
.	O

1997	O
)	O
.Immunoelectronmicroscopy5	O
mm3	O
of	O
tissue	O
was	O
obtained	O
from	O
the	O
cerebral	O
cortex	O
of	O
a	O
37-yr-old	O
woman	O
24	O
h	O
after	O
her	O
death	O
by	O
loss	O
of	O
blood	O
,	O
and	O
fixed	O
with	O
4	O
%	O
paraformaldehyde	O
.	O

Materials	O
and	O
methodsPreparation	O
of	O
human	O
skin	O
tissuesSimplate	O
II	O
bleeding-time	O
devices	O
(	O
Organon	O
Teknika	O
Corp.	O
)	O
were	O
used	O
to	O
create	O
uniform	O
incisional	O
wounds	O
(	O
5	O
mm	O
long	O
and	O
1	O
mm	O
deep	O
)	O
on	O
the	O
lateral	O
lower	O
legs	O
of	O
11	M-NUM
normal	O
male	O
and	O
3	F-NUM
normal	O
female	O
volunteers	O
.	O

After	O
a	O
series	O
of	O
PBS	O
washes	O
,	O
cells	O
were	O
serum	O
starved	O
for	O
3	O
h	O
and	O
were	O
then	O
subjected	O
to	O
treatments	O
as	O
described	O
below.Isolation	O
and	O
culture	O
of	O
rat	O
hepatocytesHepatocytes	O
were	O
isolated	O
from	O
5-mo-old	O
male	O
Fischer	O
344	O
rats	O
by	O
the	O
collagenase	O
perfusion	O
method	O
of	O
Seglen	O
(	O
Ikeyama	O
et	O
al.	O
,	O
2002	O
)	O
.	O

Altogether	O
798	M-NUM
men	O
provided	O
a	O
fresh	O
semen	O
sample	O
;	O
the	O
percentage	O
of	O
semen	O
providers	O
relative	O
to	O
all	O
men	O
who	O
were	O
encouraged	O
to	O
deliver	O
a	O
semen	O
sample	O
was	O
79	O
%	O
in	O
Greenland	O
(	O
201	O
men	O
)	O
,	O
7	O
%	O
in	O
Sweden	O
(	O
191	O
men	O
)	O
,	O
29	O
%	O
in	O
Warsaw	O
(	O
198	O
men	O
)	O
,	O
and	O
33	O
%	O
in	O
Kharkiv	O
(	O
208	O
men	O
)	O
.	O

Blood	O
samples	O
were	O
collected	O
from	O
the	O
participating	O
men	O
within	O
1	O
week	O
of	O
the	O
semen	O
sample	O
collection	O
,	O
except	O
for	O
a	O
subgroup	O
of	O
116	M-NUM
men	O
from	O
Greenland	O
,	O
who	O
had	O
their	O
blood	O
sample	O
collected	O
up	O
to	O
1	O
year	O
in	O
advance	O
.	O

A	O
total	O
of	O
365	M-NUM
men	O
were	O
available	O
with	O
one	O
,	O
two	O
,	O
or	O
all	O
three	O
receptor	O
activity	O
values	O
;	O
these	O
included	O
262	O
subjects	O
for	O
the	O
AR	O
assay	O
,	O
338	O
for	O
the	O
AhR	O
assay	O
,	O
and	O
358	O
for	O
the	O
ER	O
assay	O
.	O

Data	O
on	O
both	O
xenobiotic	O
activity	O
and	O
semen	O
quality	O
were	O
available	O
from	O
319	M-NUM
men	O
.	O

During	O
the	O
test	O
,	O
the	O
individuals	O
were	O
continuously	O
monitored	O
with	O
a	O
three-lead	O
ECG.ET	O
was	O
considered	O
positive	O
for	O
myocardial	O
ischemia	O
if	O
there	O
was	O
a	O
horizontal	O
or	O
down-sloping	O
ST-segment	O
depression	O
,	O
of	O
≥	O
1	O
mm	O
for	O
men	O
and	O
1.5	O
mm	O
for	O
women	O
,	O
at	O
80	O
ms	O
after	O
the	O
J	O
point	O
.	O

The	O
final	O
sample	O
included	O
in	O
the	O
present	O
study	O
consisted	O
of	O
70	O
individuals	O
,	O
33	M-NUM
men	O
and	O
37	F-NUM
women	O
.	O

For	O
adoptive	O
transfer	O
of	O
the	O
CML-like	O
syndrome	O
,	O
1–2	O
×	O
106	O
bone	O
marrow	O
and/or	O
splenocytes	O
from	O
primary	O
animals	O
were	O
injected	O
intravenously	O
into	O
sublethally	O
irradiated	O
(	O
450	O
cGy	O
)	O
female	O
Balb/c	O
recipient	O
mice	O
.	O

Materials	O
and	O
MethodsPatient.Material	O
from	O
a	O
previously	O
described	O
(	O
5	O
,	O
6	O
)	O
male	O
patient	O
lacking	O
neutrophil-specific	O
granules	O
was	O
studied	O
.	O

PCR	O
products	O
were	O
cloned	O
and	O
sequenced	O
by	O
standard	O
procedures.Nested	O
PCR.To	O
reevaluate	O
the	O
distribution	O
of	O
Wolbachia	O
in	O
a	O
population	O
of	O
50	F-NUM
male	O
and	O
50	O
female	O
B.	O
malayi13	O
,	O
a	O
nested	O
PCR	O
was	O
developed	O
.	O

MethodsSubjectsA	O
total	O
of	O
120	M-NUM
men	O
attending	O
obstetrics	O
and	O
gynecology	O
clinics	O
in	O
Sfax	O
(	O
South	O
of	O
Tunisia	O
)	O
for	O
diagnostic	O
semen	O
analysis	O
were	O
selected	O
to	O
the	O
study	O
after	O
they	O
gave	O
informed	O
consent	O
.	O

RA	O
patients	O
(	O
6	M-NUM
male	O
,	O
20	F-NUM
female	O
)	O
had	O
a	O
mean	O
age	O
of	O
52	O
yr	O
(	O
range	O
36–66	O
)	O
;	O
their	O
mean	O
disease	O
duration	O
was	O
6	O
yr	O
(	O
0.5–16	O
)	O
.	O

OA	O
patients	O
(	O
1	M-NUM
male	O
,	O
2	F-NUM
female	O
)	O
had	O
a	O
mean	O
age	O
of	O
68	O
(	O
62–78	O
)	O
;	O
mean	O
disease	O
duration	O
was	O
8	O
yr	O
(	O
6–12	O
)	O
.	O

MethodsSubjectsOne	O
hundred	O
and	O
nine	O
(	O
35	F-NUM
females	O
and	O
74	M-NUM
males	O
;	O
mean	O
age	O
:	O
54.6	O
±	O
16.7	O
)	O
HD	O
patients	O
were	O
enrolled	O
in	O
the	O
study	O
.	O

Of	O
the	O
rest	O
,	O
28	M-NUM
were	O
male	O
and	O
18	F-NUM
were	O
female	O
,	O
14	O
were	O
White	O
of	O
non-Hispanic	O
descent	O
,	O
14	O
White	O
of	O
Hispanic	O
descent	O
,	O
11	O
were	O
Black	O
,	O
and	O
7	O
were	O
of	O
various	O
Asian	O
origins	O
.	O

MethodsSubjectsForty	O
subjects	O
(	O
19	M-NUM
males	O
and	O
21	F-NUM
females	O
)	O
volunteered	O
to	O
participate	O
in	O
this	O
study	O
.	O

Materials	O
and	O
methodsSubjectsSynovial	O
tissues	O
from	O
26	O
RA	O
patients	O
,	O
12	M-NUM
men	O
and	O
14	F-NUM
women	O
,	O
were	O
obtained	O
through	O
the	O
rheumatology	O
clinic	O
at	O
the	O
Karolinska	O
Hospital	O
,	O
Solna	O
,	O
Sweden	O
.	O

A	O
total	O
of	O
11	M-NUM
male	O
breast	O
cancer	O
cases	O
and	O
16	F-NUM
female	O
index	O
cases	O
(	O
the	O
youngest	O
breast	O
cancer	O
case	O
in	O
the	O
family	O
from	O
which	O
biospecimens	O
were	O
available	O
)	O
were	O
screened	O
from	O
these	O
families	O
.	O

A	O
total	O
of	O
2	O
prostate	O
cancer	O
cases	O
and	O
12	O
index	O
female	O
breast	O
cancer	O
cases	O
were	O
analysed	O
from	O
these	O
families	O
.	O

Control	O
subjects	O
(	O
46	F-NUM
females	O
and	O
55	M-NUM
males	O
)	O
without	O
cancer	O
or	O
a	O
family	O
history	O
of	O
cancer	O
included	O
subjects	O
ascertained	O
via	O
the	O
Queensland	O
Blood	O
Bank	O
and	O
a	O
group	O
of	O
geriatric	O
controls	O
(	O
average	O
age	O
of	O
80	O
years	O
)	O
.Screening	O
for	O
BCoR-L1	O
variationBCoR-L1	O
is	O
expressed	O
in	O
two	O
isoforms	O
.	O

Forty-five	O
patients	O
(	O
38	F-NUM
women	O
,	O
seven	O
men	O
)	O
had	O
limited	O
cutaneous	O
SSc	O
,	O
and	O
18	O
patients	O
(	O
13	O
women	O
,	O
five	O
men	O
)	O
had	O
proximal	O
skin	O
involvement	O
and	O
fulfilled	O
the	O
criteria	O
for	O
diffuse	O
cutaneous	O
SSc	O
[	O
17	O
]	O
.	O

The	O
limits	O
of	O
detection	O
were	O
as	O
follows	O
:	O
IL-2	O
:	O
20	O
pg/ml	O
;	O
IL-4	O
:	O
20	O
pg/ml	O
;	O
IL-10	O
:	O
20	O
pg/ml	O
;	O
IFN-γ	O
:	O
60	O
pg/ml	O
;	O
TGF-β	O
:	O
60	O
pg/ml.Mice.NOD/SCID	O
female	O
mice	O
were	O
purchased	O
from	O
Charles	O
River	O
Laboratories	O
.	O

Of	O
all	O
eligible	O
individuals	O
,	O
a	O
total	O
of	O
4310	O
(	O
2193	F-NUM
females	O
,	O
2117	M-NUM
males	O
;	O
response	O
proportion	O
:	O
68.8	O
%	O
)	O
,	O
after	O
having	O
given	O
written	O
informed	O
consent	O
,	O
took	O
part	O
in	O
a	O
health	O
examination	O
.	O

Risk	O
drinking	O
was	O
defined	O
as	O
drinking	O
more	O
than	O
20	O
gr	O
pure	O
alcohol	O
per	O
day	O
among	O
women	O
,	O
and	O
more	O
than	O
30	O
gr	O
pure	O
alcohol	O
per	O
day	O
among	O
men	O
[	O
14	O
]	O
.	O

SubjectsIn	O
August	O
2002	O
,	O
we	O
enrolled	O
a	O
cohort	O
of	O
181	O
Taiwanese	O
with	O
ESRF	O
(	O
97	M-NUM
men	O
and	O
84	F-NUM
women	O
)	O
who	O
hadreceived	O
regular	O
hemodialysis	O
three	O
times	O
a	O
week	O
for	O
at	O
least	O
six	O
months	O
.	O

These	O
restrictions	O
yielded	O
97	F-NUM
women	O
and	O
290	O
urine	O
samples	O
for	O
analysis	O
.	O

The	O
samples	O
came	O
from	O
156	O
patients	O
(	O
56	F-NUM
females	O
,	O
100	M-NUM
males	O
,	O
mean	O
age	O
44.4	O
±	O
18.4	O
years	O
)	O
.	O

We	O
excluded	O
fromstatistical	O
analysis	O
18	O
subjects	O
(	O
7	M-NUM
men	O
and	O
11	F-NUM
women	O
)	O
with	O
hs-CRPconcentrations	O
≥10.0	O
mg/L	O
to	O
exclude	O
possible	O
cases	O
of	O
acute	O
infections	O
andother	O
occult	O
diseases	O
.	O

Specific	O
MLPA	O
probes	O
were	O
designed	O
for	O
HUWEI1	O
,	O
PHF8	O
,	O
EMD	O
,	O
EDA2R	O
and	O
FLNA	O
genes	O
for	O
screening	O
of	O
75	M-NUM
male	O
controls	O
(	O
see	O
Additional	O
file	O
2	O
)	O
.PCRPCR	O
was	O
always	O
performed	O
for	O
confirmation	O
of	O
our	O
array-CGH	O
data	O
when	O
losses	O
were	O
detected	O
.	O

MethodsTwelve	O
healthy	O
subjects	O
[	O
(	O
mean	O
±	O
standard	O
deviation	O
)	O
6	F-NUM
male	O
,	O
6	O
female	O
,	O
age	O
25.15	O
±	O
2.5	O
years	O
,	O
body	O
mass	O
74.1	O
±	O
11.84	O
kg	O
]	O
gave	O
informed	O
consent	O
and	O
participated	O
in	O
the	O
study	O
.	O

Smoking	O
referred	O
to	O
any	O
time	O
before	O
or	O
during	O
the	O
pregnancy	O
;	O
only	O
10	F-NUM
women	O
smoked	O
during	O
pregnancy.We	O
measured	O
poverty	O
status	O
using	O
national	O
standards	O
,	O
based	O
on	O
monthly	O
per	O
capita	O
income	O
in	O
Mexican	O
pesos	O
.	O

Lipolysis	O
and	O
lipogenesis	O
were	O
investigated	O
in	O
204	F-NUM
obese	O
women	O
in	O
sample	O
3	O
.	O

ESR1	O
mRNA	O
levels	O
in	O
adipose	O
tissue	O
were	O
quantified	O
in	O
the	O
122	F-NUM
women	O
of	O
sample	O
3	O
for	O
which	O
RNA	O
was	O
available	O
.	O

The	O
control	O
human	O
plasma	O
pool	O
3	M-NUM
was	O
a	O
hyperimmune	O
pool	O
made	O
from	O
7	F-NUM
Tanzanian	O
women	O
and	O
3	O
male	O
.	O

Blood	O
samples	O
and	O
donor	O
eyesSix	O
normal	O
human	O
donor	O
eyes	O
withno	O
clinical	O
signs	O
of	O
uveitis	O
(	O
2	F-NUM
female	O
,	O
4	M-NUM
male	O
;	O
mean	O
age	O
46	O
years	O
)	O
were	O
usedfor	O
evaluation	O
of	O
CRALBP	O
expression	O
pattern	O
in	O
normal	O
eyes	O
.	O

All	O
donors	O
gave	O
their	O
informed	O
consent.Peripheral	O
blood	O
samples	O
of	O
56patients	O
(	O
34	M-NUM
male	O
,	O
22	F-NUM
female	O
;	O
mean	O
age	O
36	O
years	O
;	O
white	O
Europeans	O
)	O
with	O
uveitis	O
and23	O
eye-healthy	O
control	O
subjects	O
(	O
7	O
male	O
,	O
16	O
female	O
;	O
mean	O
age	O
34years	O
;	O
white	O
Europeans	O
)	O
were	O
used	O
for	O
this	O
study	O
.	O

A	O
total	O
of	O
600	F-NUM
women	O
were	O
identified	O
.	O

Lymphocyte	O
DNA	O
extracted	O
from	O
the	O
600	F-NUM
French-Canadian	O
women	O
with	O
breast	O
cancer	O
was	O
undertaken	O
using	O
standard	O
methods	O
.	O

Materials	O
and	O
methodsRheumatoid	O
arthritis	O
patientsPatients	O
(	O
n	O
=	O
40	O
)	O
,	O
including	O
13	M-NUM
men	O
and	O
27	F-NUM
women	O
with	O
a	O
mean	O
age	O
of	O
53	O
years	O
(	O
range	O
22–78	O
years	O
)	O
,	O
were	O
recruited	O
at	O
first	O
presentation	O
between	O
May	O
2004	O
and	O
December	O
2005	O
when	O
attending	O
scheduled	O
appointments	O
at	O
our	O
specialized	O
early	O
RA	O
clinic	O
.	O

Cooperative	O
State	O
Research	O
,	O
Education	O
,	O
and	O
Extension	O
Service	O
(	O
CSREES	O
)	O
agents	O
,	O
who	O
serve	O
as	O
leaders	O
on	O
health	O
issues	O
in	O
rural	O
communities	O
,	O
recruited	O
a	O
purposive	O
,	O
nonrandom	O
sample	O
of	O
sedentary	O
women	O
aged	O
40	O
or	O
older	O
.	O

In	O
total	O
,	O
38	F-NUM
women	O
participated	O
,	O
with	O
group	O
sizes	O
ranging	O
from	O
8	O
to	O
11	O
participants	O
.	O

Materials	O
and	O
MethodsPatients	O
and	O
tissue	O
collectionPancreas	O
tissues	O
were	O
obtained	O
intraoperatively	O
from	O
patients	O
undergoing	O
resection	O
for	O
chronic	O
pancreatitis	O
(	O
21	M-NUM
men	O
,	O
19	F-NUM
women	O
)	O
.	O

The	O
mean	O
age	O
of	O
the	O
women	O
was	O
33	O
years	O
(	O
range	O
31–37	O
)	O
,	O
4	O
were	O
primagravida	O
and	O
4	O
were	O
multigravida	O
.	O

Plasma	O
samples	O
were	O
collected	O
from	O
55	O
healthy	O
blood	O
donors	O
as	O
well	O
as	O
40	F-NUM
women	O
with	O
metastatic	O
breast	O
cancer	O
(	O
Dr.	O
Susan	O
Miesfeldt	O
,	O
Maine	O
Center	O
for	O
Cancer	O
Medicine	O
and	O
Blood	O
Disorders	O
,	O
Scarborough	O
,	O
Maine	O
)	O
.	O

The	O
current	O
investigation	O
included	O
145	O
trios	O
(	O
77	M-NUM
male	O
,	O
68	F-NUM
female	O
adolescents	O
and	O
their	O
parents	O
)	O
for	O
whom	O
complete	O
genotype	O
and	O
phenotype	O
data	O
were	O
available	O
.	O

Some	O
sections	O
were	O
counterstained	O
with	O
hematoxylin	O
to	O
visualize	O
the	O
nucleus.Retinal	O
specimens	O
from	O
a	O
46	O
year	O
old	O
female	O
donor	O
became	O
available	O
(	O
University	O
of	O
Regensburg	O
,	O
Germany	O
)	O
within	O
1	O
h	O
after	O
enucleation	O
due	O
to	O
severe	O
herpes	O
simplex	O
keratitis	O
.	O

MethodsA	O
double-blind	O
,	O
placebo-controlled	O
,	O
randomized	O
,	O
crossover	O
protocol	O
was	O
used	O
to	O
administer	O
10	O
mg	O
of	O
loratadine	O
(	O
a	O
powdered	O
tablet	O
)	O
capsule	O
or	O
placebo	O
(	O
lactose	O
)	O
capsule	O
in	O
9	O
volunteer	O
subjects	O
(	O
8	M-NUM
males	O
and	O
1	F-NUM
female	O
)	O
.	O

This	O
group	O
included	O
44	F-NUM
females	O
and	O
89	M-NUM
males	O
with	O
a	O
mean	O
age	O
of	O
18.7	O
±	O
4.5	O
years	O
.	O

Donors	O
were	O
aged	O
between	O
21	O
and	O
53	O
years	O
old	O
,	O
2	F-NUM
females	O
and	O
4	M-NUM
males	O
,	O
3	O
knees	O
were	O
left	O
and	O
3	O
were	O
right	O
.	O

In	O
vitro	O
panning-selected	O
lines	O
were	O
characterized	O
by	O
reactivity	O
with	O
IgG	O
from	O
multiparous	O
women	O
and	O
lack	O
of	O
reactivity	O
with	O
IgG	O
from	O
P.	O
falciparum-exposed	O
men	O
[	O
6	O
]	O
,	O
[	O
9	O
]	O
,	O
[	O
35	O
]	O
.DNA	O
and	O
total	O
RNA	O
extractionsGenomic	O
DNA	O
was	O
extracted	O
from	O
filter	O
spots	O
using	O
the	O
chelex	O
procedure	O
[	O
36	O
]	O
.	O

Due	O
to	O
the	O
variable	O
distribution	O
of	O
late	O
stages	O
in	O
different	O
isolates	O
after	O
placental	O
perfusion	O
(	O
thin	O
smears	O
reads	O
against	O
200	O
parasites	O
)	O
,	M-NUM
RNA	O
samples	O
from	O
18	F-NUM
women	O
were	O
pooled	O
into	O
3	O
groups	O
.	O

Two	O
panels	O
of	O
plasma	O
samples	O
from	O
P.	O
falciparum	O
thick	O
blood	O
smear	O
negative	O
Ghanaian	O
individuals	O
(	O
30	F-NUM
women	O
of	O
various	O
gravidity	O
and	O
30	O
sympatric	O
males	O
)	O
exposed	O
to	O
hyperendemic	O
and	O
seasonal	O
malaria	O
transmission	O
were	O
used	O
[	O
15	O
]	O
.	O

MethodsPatients	O
and	O
samplesThe	O
IBC	O
samples	O
were	O
surgical	O
biopsy	O
specimens	O
obtained	O
from	O
35	F-NUM
women	O
treated	O
at	O
Saint-Louis	O
Hospital	O
,	O
Paris	O
,	O
France	O
,	O
between	O
1988	O
and	O
1995	O
.	O

Approximately	O
25	O
%	O
of	O
the	O
telephone	O
interviewers	O
were	O
Black	O
and	O
55	F-NUM
%	O
were	O
females	O
.	O

Across	O
all	O
genotypes	O
the	O
sample	O
was	O
42	O
%	O
MZ	O
(	O
MZ	O
female	O
:	O
23	F-PER
%	O
;	O
MZ	O
male	O
:	O
19	M-PER
%	O
)	O
,	O
32	O
%	O
DZ	O
(	O
DZ	O
female	O
:	O
17	O
%	O
;	O
DZ	O
male	O
:	O
15	O
%	O
)	O
,	O
and	O
26	O
%	O
opposite-sex	O
DZ.The	O
mean	O
ages	O
of	O
the	O
twins	O
when	O
questionnaires	O
were	O
returned	O
were	O
4.05	O
(	O
s.d	O
.	O

Group	O
1	O
consisted	O
of	O
young	O
healthy	O
subjects	O
without	O
any	O
metallic	O
implants	O
(	O
n	O
=	O
8	O
,	O
4	F-NUM
male	O
and	O
4	O
female	O
subjects	O
with	O
an	O
average	O
age	O
of	O
29	O
,	O
range	O
23	O
to	O
36	O
)	O
and	O
was	O
primarily	O
used	O
for	O
determination	O
of	O
relative	O
metal	O
toxicity	O
and	O
upper	O
limits	O
of	O
challenge	O
dose	O
.	O

[	O
19	O
]	O
Group	O
3	O
subjects	O
were	O
age-matched	O
controls	O
(	O
to	O
Group	O
2	O
)	O
with	O
no	O
implants	O
(	O
Group	O
3	O
,	O
n	O
=	O
8	O
,	O
4	F-NUM
male	O
,	O
4	O
female	O
,	O
average	O
age	O
70	O
,	O
range	O
49	O
to	O
80	O
)	O
.	O

The	O
median	O
age	O
was	O
58	O
years	O
(	O
range	O
:	O
18–86	O
)	O
with	O
a	O
male/female	O
ratio	O
of	O
2	O
:	O
1	O
(	O
142	M-NUM
male	O
and	O
70	F-NUM
female	O
)	O
.	O

The	O
original	O
study	O
population	O
comprised	O
aprospective	O
series	O
of	O
300	M-NUM
males	O
aged	O
33–70	O
years	O
(	O
mean	O
53years	O
)	O
.	O

MATERIALS	O
AND	O
METHODSPatientsNineteen	O
patients	O
(	O
9	M-NUM
men	O
and	O
10	F-NUM
women	O
,	O
average	O
age	O
51.5	O
years	O
)	O
with	O
metastases	O
from	O
solid	O
tumors	O
were	O
included	O
in	O
the	O
study	O
.	O

The	O
average	O
age	O
was	O
31.6	O
years	O
(	O
range	O
:	O
18–66	O
)	O
and	O
58	F-NUM
%	O
were	O
female	O
.	O

Each	O
MS	O
sample	O
was	O
compared	O
to	O
the	O
female	O
reference	O
(	O
pool	O
of	O
20	F-NUM
females	O
)	O
.	O

MethodsPatientsThe	O
study	O
group	O
consisted	O
of	O
22	F-NUM
women	O
with	O
clinical	O
and	O
histopathological	O
diagnosis	O
of	O
squamous	O
cell	O
carcinoma	O
of	O
the	O
cervix	O
,	M-NUM
21	O
women	O
with	O
CIN	O
1	O
(	O
Cervical	O
Intraepithelial	O
Neoplasia	O
grade	O
1	O
–	O
mild	O
dysplasia	O
)	O
and	O
20	O
healthy	O
female	O
volunteers	O
.	O

Patients	O
and	O
methodsPatients	O
and	O
serum	O
samplesWe	O
analysed	O
serum	O
samples	O
from	O
203	O
Japanese	O
patients	O
with	O
SSc	O
(	O
173	M-NUM
women	O
and	O
30	F-NUM
men	O
)	O
.	O

:1	O
112	O
patients	O
(	O
104	F-NUM
women	O
and	O
eight	O
men	O
)	O
had	O
lSSc	O
and	O
91	O
patients	O
(	O
69	O
women	O
and	O
22	O
men	O
)	O
had	O
dSSc	O
.	O

Patients	O
and	O
methodsWe	O
studied	O
25	O
severe	O
RHD	O
patients	O
,	O
17	M-NUM
males	O
and	O
8	F-NUM
females	O
who	O
underwent	O
cardiac	O
valvular	O
surgery	O
before	O
16	O
years	O
of	O
age	O
,	O
in	O
which	O
14	O
(	O
56	O
%	O
)	O
presented	O
an	O
acute	O
RF	O
episode	O
.	O

In	O
the	O
keratoconus	O
group	O
,	O
the	O
mean	O
age	O
was	O
25	O
years	O
(	O
range	O
14–48	O
years	O
)	O
,	O
68	M-PER
%	O
were	O
male	O
and	O
32	F-PER
%	O
were	O
female	O
.	O

The	O
ages	O
of	O
the	O
68	M-NUM
male	O
and	O
38	F-NUM
female	O
patients	O
ranged	O
from	O
31	O
to	O
85	O
years	O
.	O

Per	O
treatment	O
group	O
10	F-NUM
female	O
inbred	O
nude	O
(	O
Balb/c	O
nu/nu	O
)	O
mice	O
(	O
Charles	O
River	O
,	O
St	O
.	O

For	O
control	O
purposes	O
,	O
BPH	O
lesions	O
from	O
37	M-NUM
men	O
without	O
prostate	O
cancer	O
that	O
underwent	O
transurethral	O
resection	O
(	O
TURP	O
)	O
of	O
the	O
prostate	O
were	O
also	O
collected	O
.	O

Severe	O
combined	O
immunodeficiency	O
mice	O
(	O
age	O
24–28	O
weeks	O
;	O
strain	O
C.B-17/Ztm-scid	O
of	O
both	O
sexes	O
;	O
weight	O
24–26	O
,	O
4	O
g	O
(	O
female	O
)	O
and	O
26	O
,	O
3–32	O
,	O
4	O
g	O
(	O
male	O
)	O
)	O
were	O
used	O
for	O
the	O
tumour	O
implantation	O
.	O

Of	O
those	O
approached	O
,	O
102	F-NUM
women	O
enrolled	O
in	O
the	O
study	O
,	O
89	O
participants	O
completed	O
baseline	O
measures	O
,	O
79	O
completed	O
3-week	O
follow-up	O
measures	O
,	O
and	O
71	O
completed	O
3-month	O
follow-up	O
measures	O
.	O

Among	O
the	O
52	F-NUM
women	O
with	O
breast	O
cancer	O
,	O
17	O
had	O
breast	O
cancer	O
in	O
complete	O
remission	O
,	O
19	O
had	O
radiological	O
evidence	O
of	O
bone	O
metastases	O
only	O
,	O
and	O
16	O
had	O
metastases	O
at	O
non-bone	O
sites	O
(	O
hepatic	O
,	O
cutaneous	O
,	O
lymph	O
node	O
,	O
and	O
lung	O
)	O
(	O
Table	O
1	O
)	O
.	O

The	O
mean	O
age	O
of	O
patients	O
with	O
colorectal	O
cancer	O
(	O
72	M-NUM
male	O
and	O
25	F-NUM
female	O
)	O
was	O
64	O
and	O
ranged	O
from	O
38	O
to	O
90	O
years	O
.	O

MATERIALS	O
AND	O
METHODSPatientsForty	O
patients	O
(	O
35	M-NUM
men	O
and	O
five	O
women	O
)	O
who	O
underwent	O
radical	O
nephrectomy	O
for	O
RCC	O
between	O
1991	O
and	O
2001	O
at	O
our	O
institution	O
and	O
presented	O
with	O
metastasis	O
at	O
the	O
time	O
of	O
operation	O
were	O
recruited	O
in	O
this	O
study	O
(	O
Table	O
1	O
)	O
.	O

The	O
group	O
consisted	O
of	O
69	M-NUM
male	O
and	O
44	F-NUM
female	O
patients	O
,	O
mean	O
age	O
was	O
64	O
years	O
.	O

There	O
were	O
87	M-NUM
men	O
and	O
16	F-NUM
women	O
.	O

A	O
total	O
of	O
1158	F-NUM
women	O
aged	O
16–23	O
years	O
were	O
recruited	O
in	O
Brazil	O
,	O
Nordic	O
countries	O
(	O
Finland	O
,	O
Sweden	O
,	O
Norway	O
)	O
,	O
and	O
the	O
USA	O
.	O

Cell	O
number	O
and	O
viability	O
were	O
evaluated	O
by	O
Trypan	O
blue	O
exclusion	O
test.MiceA	O
total	O
of	O
10	M-NUM
male	O
triple-deficient	O
BALB/c	O
nude	O
mice	O
at	O
6	O
weeks	O
of	O
age	O
were	O
purchased	O
from	O
JAPAN	O
SLC	O
.	O

MATERIALS	O
AND	O
METHODSSubcutaneous	O
tumours	O
were	O
generated	O
by	O
injecting	O
human	O
HT-29	O
cells	O
in	O
the	O
dorsal	O
flank	O
of	O
55	F-NUM
female	O
severe	O
combined	O
immunodeficiency	O
(	O
SCID	O
)	O
mice	O
,	O
and	O
allowed	O
to	O
grow	O
to	O
a	O
diameter	O
of	O
0.5	O
cm	O
(	O
approximately	O
3	O
weeks	O
)	O
.	O

MATERIAL	O
AND	O
METHODSThe	O
EPIC	O
studyThe	O
EPIC	O
cohort	O
consists	O
of	O
about	O
370	O
000	O
women	O
and	O
150	O
000	O
men	O
,	O
aged	O
35–69	O
years	O
,	O
recruited	O
between	O
1992	O
and	O
1998	O
in	O
23	O
research	O
centres	O
in	O
10	O
Western	O
European	O
countries	O
.	O

PATIENTS	O
AND	O
METHODSPatients	O
and	O
controlsThis	O
study	O
includes	O
59	O
patients	O
with	O
metastatic	O
breast	O
cancer	O
,	O
36	O
patients	O
with	O
localised	O
breast	O
cancer	O
and	O
24	F-NUM
healthy	O
women	O
as	O
control	O
subjects	O
.	O

The	O
control	O
subjects	O
for	O
autoantibody	O
prevalence	O
were	O
24	F-NUM
healthy	O
women	O
,	O
with	O
a	O
median	O
age	O
of	O
53	O
years	O
(	O
range	O
28–59	O
)	O
.	O

The	O
population	O
in	O
the	O
county	O
was	O
260	O
472	O
inhabitants	O
of	O
whom	O
130	O
651	O
were	O
women	O
in	O
1995	O
.	O

MATERIALS	O
AND	O
METHODSStudy	O
populationA	O
total	O
number	O
of	O
512	F-NUM
women	O
enrolled	O
in	O
the	O
surveillance	O
programme	O
for	O
hereditary	O
ovarian	O
cancer	O
from	O
January	O
1995	O
until	O
January	O
2005	O
at	O
the	O
Family	O
Cancer	O
Clinic	O
of	O
the	O
Radboud	O
University	O
Nijmegen	O
Medical	O
Centre	O
,	O
The	O
Netherlands	O
.	O

Between	O
1995	O
and	O
1999	O
women	O
enrolled	O
in	O
the	O
surveillance	O
programme	O
through	O
self-reference	O
,	O
reference	O
by	O
the	O
department	O
of	O
human	O
genetics	O
,	O
the	O
general	O
practitioner	O
or	O
other	O
specialists	O
.	O

After	O
1999	O
,	O
women	O
were	O
first	O
counselled	O
at	O
the	O
department	O
of	O
human	O
genetics	O
and	O
referred	O
to	O
the	O
gynaecologist	O
when	O
indicated	O
.	O

Primary	O
tumour	O
tissue	O
specimens	O
and	O
corresponding	O
normal	O
tissue	O
controls	O
were	O
obtained	O
from	O
55	O
Japanese	O
patients	O
who	O
underwent	O
surgery	O
for	O
oesophageal	O
carcinoma	O
(	O
47	M-NUM
men	O
and	O
8	F-NUM
women	O
;	O
median	O
age	O
,	O
61	O
years	O
;	O
range	O
,	O
40–82	O
years	O
)	O
.	O

MATERIALS	O
AND	O
METHODSPatients	O
and	O
materialsThe	O
present	O
study	O
included	O
30	O
tumour	O
samples	O
from	O
26	O
patients	O
(	O
8	F-NUM
women	O
and	O
18	M-NUM
men	O
,	O
median	O
age	O
60	O
years	O
)	O
.	O

In	O
all	O
,	O
14	M-NUM
patients	O
were	O
males	O
and	O
nine	O
were	O
female	O
.	O

Peritoneal	O
fluids	O
were	O
obtained	O
from	O
99	F-NUM
women	O
,	O
who	O
gave	O
signed	O
informed	O
consent	O
(	O
Table	O
1	O
)	O
.	O

MATERIAL	O
AND	O
METHODSWe	O
analysed	O
frozen	O
tissue	O
from	O
excised	O
primary	O
breast	O
tumours	O
of	O
230	F-NUM
women	O
treated	O
in	O
the	O
health-care	O
region	O
of	O
southeast	O
Sweden	O
between	O
1985	O
and	O
1991	O
.	O

Healthy	O
bone	O
marrow	O
donors	O
(	O
2	M-NUM
men	O
,	O
26	O
,	O
32	O
years	O
)	O
and	O
healthy	O
controls	O
(	O
10/12	O
,	O
39	O
,	O
22–62	O
)	O
were	O
enrolled	O
in	O
order	O
to	O
study	O
medullary	O
or	O
circulating	O
plasma	O
cells.Medical	O
records	O
of	O
157	O
GBS	O
patients	O
(	O
91/66	O
,	O
47	O
,	O
15–83	O
)	O
,	O
referred	O
to	O
our	O
institution	O
between	O
April	O
1990	O
and	O
May	O
2004	O
,	O
were	O
reviewed	O
.	O

There	O
were	O
16	O
patients	O
(	O
four	O
women	O
and	O
12	M-NUM
men	O
)	O
with	O
the	O
age	O
ranging	O
from	O
20	O
to	O
69	O
years	O
(	O
average	O
31.2	O
years	O
)	O
.	O

The	O
median	O
age	O
at	O
diagnosis	O
was	O
67	O
years	O
for	O
males	O
(	O
range	O
26–94	O
)	O
and	O
69	O
years	O
for	O
females	O
(	O
range	O
24–92	O
)	O
.	O

There	O
were	O
33	M-NUM
males	O
and	O
17	F-NUM
females	O
with	O
a	O
mean	O
age	O
of	O
62.2	O
years	O
(	O
range	O
from	O
36–83	O
)	O
.	O

Bone	O
marrow	O
samples	O
obtained	O
by	O
aspiration	O
were	O
collected	O
after	O
an	O
acquisition	O
of	O
informed	O
consent	O
from	O
183	O
consecutive	O
patients	O
(	O
106	M-NUM
male	O
;	O
77	F-NUM
female	O
)	O
who	O
were	O
diagnosed	O
with	O
de	O
novo	O
ALL	O
between	O
January	O
1989	O
and	O
December	O
2002	O
.	O

Responses	O
are	O
coded	O
1	O
for	O
cases	O
and	O
0	O
for	O
controls	O
;	O
females	O
are	O
coded	O
1	O
and	O
males	O
0	O
;	O
smokers	O
as	O
1	O
and	O
non-smokers	O
as	O
0	O
.	O

Contact	O
was	O
successful	O
for	O
234	O
men	O
in	O
Arnsberg	O
and	O
296	O
in	O
Brilon	O
.	O

Based	O
on	O
the	O
evaluation	O
of	O
the	O
questionnaire	O
data	O
,	O
100	M-NUM
men	O
with	O
the	O
highest	O
self-reported	O
tap	O
water	O
consumption	O
were	O
selected	O
to	O
participate	O
in	O
Arnsberg	O
and	O
Brilon	O
,	O
respectively.For	O
the	O
recruitment	O
of	O
mothers	O
and	O
children	O
,	O
we	O
chose	O
a	O
different	O
approach	O
.	O

Materials	O
and	O
MethodsParticipantsTen	O
undergraduate	O
students	O
from	O
McGill	O
University	O
participated	O
in	O
the	O
study	O
(	O
2	M-NUM
males	O
,	O
mean	O
age	O
of	O
19.1	O
years	O
)	O
.	O

Materials	O
and	O
methodsSamples	O
were	O
obtained	O
from	O
40	O
patients	O
(	O
15	M-NUM
men	O
aged	O
50	O
to	O
79	O
years	O
,	O
and	O
25	F-NUM
women	O
aged	O
47	O
to	O
87	O
years	O
)	O
presenting	O
for	O
total	O
hip	O
replacement	O
surgery	O
for	O
OA	O
.	O

Their	O
mean	O
age	O
was	O
47.7	O
±	O
15.0	O
years	O
,	O
and	O
13	F-NUM
were	O
male	O
and	O
20	M-NUM
were	O
female.All	O
of	O
the	O
patients	O
were	O
under	O
the	O
care	O
of	O
the	O
Yokohama	O
City	O
University	O
Hospital	O
.	O

MethodsTumor	O
tissueAll	O
30	O
patients	O
,	O
24	M-NUM
men	O
and	O
6	F-NUM
women	O
with	O
a	O
mean	O
age	O
of	O
64	O
(	O
range	O
54–78	O
)	O
years	O
,	O
were	O
recruited	O
from	O
the	O
southern	O
Sweden	O
health	O
care	O
region	O
and	O
had	O
undergone	O
primary	O
esophagectomy	O
at	O
the	O
Department	O
of	O
Surgery	O
,	O
Lund	O
University	O
Hospital	O
.	O

Materials	O
and	O
MethodsPopulation	O
samples	O
were	O
collected	O
by	O
drawing	O
blood	O
from	O
the	O
upper	O
arms	O
of	O
405	M-NUM
male	O
volunteers	O
of	O
Hainan	O
aborigines	O
.	O

Materials	O
and	O
methodsParticipantsData	O
come	O
from	O
the	O
CHASRS	O
-	O
a	O
5-year	O
cohort	O
analysis	O
of	O
psychological	O
,	O
social	O
,	O
economic	O
,	O
and	O
biomedical	O
outcomes	O
in	O
230	O
English-speaking	O
men	O
and	O
women	O
aged	O
50-67	O
years	O
at	O
study	O
entry	O
[	O
43	O
]	O
.	O

Cohorts	O
of	O
age	O
matched	O
female	O
(	O
40	O
to	O
80	O
,	O
depending	O
on	O
the	O
experiment	O
)	O
NODscid/β2m−/−	O
were	O
injected	O
i.p	O
.	O

METHODSPatientsFrom	O
December	O
1994	O
to	O
August	O
1997	O
we	O
enrolled	O
37	O
high	O
grade	O
glioma	O
patients	O
,	O
17	O
with	O
grade	O
III	O
glioma	O
(	O
anaplastic	O
astrocytoma	O
AA	O
;	O
oligodendroglioma	O
OD	O
;	O
oligoastrocytoma	O
OA	O
)	O
and	O
20	O
with	O
GBM	O
;	O
16	F-NUM
were	O
females	O
and	O
21	M-NUM
were	O
males	O
,	O
age	O
range	O
was	O
19–83	O
years	O
.	O

MATERIALS	O
AND	O
METHODSPatientsGroup	O
A	O
is	O
the	O
control	O
group	O
and	O
consists	O
of	O
30	F-NUM
female	O
volunteers	O
.	O

The	O
first	O
group	O
was	O
composed	O
of	O
477	F-NUM
women	O
,	O
who	O
at	O
the	O
time	O
of	O
surgery	O
had	O
no	O
metastases	O
seen	O
on	O
histological	O
assessment	O
of	O
H	O
&	O
E	O
sections	O
of	O
the	O
axillary	O
lymph	O
nodes	O
.	O

There	O
were	O
153	O
breast	O
cancer	O
related	O
deaths.The	O
second	O
group	O
was	O
composed	O
of	O
202	F-NUM
women	O
,	O
who	O
had	O
a	O
single	O
involved	O
node	O
identified	O
on	O
histological	O
assessment	O
of	O
H	O
&	O
E	O
sections	O
of	O
the	O
axillary	O
lymph	O
nodes	O
at	O
the	O
time	O
of	O
surgery	O
.	O

Their	O
median	O
age	O
was	O
59	O
(	O
55–65	O
)	O
years	O
and	O
there	O
were	O
30	M-NUM
men	O
and	O
20	F-NUM
women.PatientsThe	O
study	O
included	O
524	O
consecutive	O
patients	O
scheduled	O
to	O
undergo	O
elective	O
resection	O
of	O
primary	O
CRC	O
.	O

The	O
median	O
age	O
of	O
the	O
patients	O
at	O
the	O
time	O
of	O
operation	O
was	O
69	O
(	O
33–90	O
)	O
years	O
,	O
and	O
316	M-NUM
men	O
and	O
208	F-NUM
women	O
were	O
included	O
.	O

MATERIALS	O
AND	O
METHODSPatients	O
and	O
samplesWe	O
analyzed	O
tissue	O
from	O
excised	O
primary	O
breast	O
tumours	O
of	O
134	F-NUM
women	O
treated	O
at	O
the	O
Centre	O
René	O
Huguenin	O
from	O
1977	O
to	O
1989	O
.	O

Inclusion	O
criteria	O
for	O
cases	O
were	O
defined	O
to	O
be	O
women	O
under	O
75	O
years	O
of	O
age	O
,	O
who	O
were	O
residents	O
(	O
at	O
least	O
10	O
years	O
residence	O
in	O
Zhejiang	O
province	O
)	O
and	O
who	O
had	O
been	O
histopathologically	O
diagnosed	O
with	O
epithelial	O
ovarian	O
cancer	O
in	O
the	O
past	O
3	O
years	O
.	O

A	O
total	O
of	O
601	F-NUM
women	O
were	O
recruited	O
from	O
the	O
same	O
hospitals	O
where	O
the	O
cases	O
were	O
identified	O
.	O

The	O
51	F-NUM
community	O
women	O
were	O
interviewed	O
at	O
their	O
homes	O
,	O
community	O
areas	O
near	O
their	O
homes	O
or	O
their	O
work	O
places.Data	O
managementAll	O
data	O
were	O
reviewed	O
for	O
completeness	O
at	O
the	O
end	O
of	O
each	O
interview	O
.	O

The	O
other	O
half	O
of	O
the	O
tissue	O
was	O
stored	O
at	O
−80°C	O
until	O
needed.PatientsThe	O
subjects	O
(	O
57	O
OSCC	O
patients	O
)	O
included	O
54	O
men	O
and	O
three	O
women	O
,	O
age	O
at	O
time	O
of	O
surgery	O
was	O
65.2±1.2	O
years	O
(	O
mean±standard	O
error	O
;	O
median	O
,	O
67	O
;	O
range	O
45–84	O
)	O
.	O

In	O
all	O
,	O
24	O
patients	O
(	O
10	F-NUM
female	O
,	O
14	M-NUM
male	O
,	O
age	O
range	O
47–81	O
(	O
median	O
age	O
69	O
)	O
years	O
)	O
were	O
included	O
.	O

MATERIALS	O
AND	O
METHODSPatients	O
and	O
controlsThe	O
study	O
included	O
50	O
patients	O
(	O
28	M-NUM
men	O
and	O
22	F-NUM
women	O
,	O
mean	O
age	O
63	O
.	O

There	O
were	O
30	M-NUM
males	O
and	O
17	F-NUM
females	O
with	O
a	O
mean	O
age	O
of	O
64.8	O
years	O
(	O
range	O
36–83	O
)	O
.	O

MATERIALS	O
AND	O
METHODSPatientsSurgical	O
specimens	O
were	O
obtained	O
from	O
81	O
patients	O
(	O
70	M-NUM
males	O
and	O
11	F-NUM
females	O
)	O
with	O
oesophageal	O
SCC	O
,	O
who	O
underwent	O
potentially	O
curative	O
surgery	O
at	O
the	O
Department	O
of	O
Surgery	O
I	O
,	O
Gunma	O
University	O
Faculty	O
of	O
Medicine	O
,	O
between	O
1983	O
and	O
2000	O
.	O

MethodsPatientsThe	O
samples	O
were	O
obtained	O
in	O
the	O
years	O
1999	O
–	O
2002	O
from	O
women	O
who	O
underwent	O
partial	O
breast	O
resection	O
or	O
radical	O
mastectomy	O
at	O
the	O
General	O
Faculty	O
Hospital	O
in	O
Prague	O
.	O

MethodsStudy	O
participantsThis	O
study	O
included	O
204	O
individuals	O
(	O
98	M-NUM
males	O
and	O
106	F-NUM
females	O
)	O
aged	O
30	O
(	O
26–34	O
)	O
years	O
.	O

Plasma	O
was	O
immediately	O
separated	O
and	O
frozen	O
at	O
-80°C	O
and	O
stored	O
until	O
assayed.Isolation	O
of	O
monocytesBlood	O
monocytes	O
were	O
obtained	O
from	O
26	O
individuals	O
at	O
age	O
32–34	O
years	O
:	O
PiMM	O
(	O
n	O
=	O
11	O
,	O
8	M-NUM
males	O
and	O
3	F-NUM
females	O
)	O
,	O
PiZZ	O
(	O
n	O
=	O
9	O
,	O
5	O
males	O
and	O
4	O
females	O
)	O
and	O
PiSZ	O
(	O
n	O
=	O
6	O
,	O
4	O
males	O
and	O
2	O
females	O
)	O
.	O

Adipose	O
tissue	O
was	O
taken	O
from	O
the	O
abdomen	O
(	O
n	O
=	O
12	O
)	O
and	O
the	O
hip/thigh	O
region	O
(	O
n	O
=	O
10	O
)	O
during	O
cosmetic	O
surgery	O
;	O
22	F-NUM
female	O
donors	O
were	O
included	O
in	O
this	O
study	O
.	O

All	O
cell	O
lines	O
were	O
karyotypically	O
normal	O
;	O
GGO	O
and	O
HSA	O
were	O
female	O
,	O
HLA	O
was	O
a	O
male.Human	O
spermHuman	O
sperm	O
sample	O
was	O
collected	O
in	O
a	O
sterile	O
container	O
after	O
3	O
days	O
of	O
sexual	O
abstinence	O
from	O
a	O
fertile	O
,	O
28	O
year-old	O
man	O
with	O
normal	O
seminal	O
parameters	O
and	O
a	O
normal	O
karyotype	O
.	O

There	O
were	O
77	M-NUM
men	O
and	O
14	F-NUM
women	O
,	O
aged	O
40−78	O
years	O
(	O
mean	O
age	O
:	O
61.0	O
years	O
)	O
.	O

There	O
were	O
47	M-NUM
male	O
and	O
32	F-NUM
female	O
patients	O
with	O
a	O
median	O
age	O
of	O
58	O
years	O
(	O
range	O
22–83	O
years	O
)	O
.	O

MATERIALS	O
AND	O
METHODSPatientsBetween	O
November	O
1998	O
and	O
April	O
2002	O
,	O
24	O
patients	O
,	O
14	F-NUM
females	O
and	O
10	M-NUM
males	O
,	O
aged	O
19–83	O
years	O
,	O
with	O
AJCC	O
stage	O
III–IV	O
melanoma	O
,	O
were	O
included	O
in	O
this	O
study	O
.	O

The	O
group	O
consisted	O
of	O
80	M-NUM
men	O
and	O
30	F-NUM
women	O
with	O
a	O
mean	O
age	O
of	O
59.6	O
years	O
(	O
range	O
39–78	O
)	O
.	O

Breast	O
tumour	O
tissues	O
were	O
obtained	O
from	O
14	F-NUM
female	O
patients	O
at	O
participating	O
hospitals	O
of	O
the	O
Ontario	O
Provincial	O
Steroid	O
Hormone	O
Receptor	O
Program	O
.	O

Incubation	O
videos	O
were	O
scored	O
for	O
number	O
of	O
parental	O
visits	O
to	O
the	O
nest	O
,	O
nest	O
attentiveness	O
(	O
measured	O
as	O
percentage	O
of	O
6	O
h	O
that	O
females	O
sat	O
on	O
the	O
nest	O
)	O
,	O
and	O
mean	O
duration	O
of	O
incubation	O
on	O
and	O
off-bouts	O
[	O
25	O
]	O
,	O
[	O
42	O
]	O
.	O

MethodsSpecimensWe	O
tested	O
83	O
clinical	O
samples	O
of	O
fasting	O
sera	O
consecutively	O
obtained	O
from	O
patients	O
(	O
49	M-NUM
men	O
and	O
34	F-NUM
women	O
)	O
,	O
aged	O
61	O
±	O
10	O
years	O
,	O
without	O
diabetes	O
,	O
hypertension	O
and	O
medications	O
for	O
hyperlipidemia	O
,	O
diabetes	O
,	O
and	O
hypertension	O
at	O
outpatient	O
clinics	O
of	O
Jikei	O
University	O
Hospital	O
,	O
Japan	O
.	O

MethodsFifteen	O
young	O
healthy	O
individuals	O
(	O
8	M-NUM
male	O
and	O
7	F-NUM
female	O
,	O
age	O
:	O
24.5	O
±	O
3.4	O
years	O
,	O
height	O
:	O
1.66	O
±	O
0.12	O
m	O
,	O
and	O
mass	O
:	O
68.5	O
±	O
8.0	O
kg	O
)	O
volunteered	O
to	O
participate	O
.	O

Of	O
these	O
patients	O
,	O
five	O
were	O
females	O
and	O
77	M-NUM
males	O
,	O
ranging	O
in	O
age	O
from	O
37	O
to	O
72	O
years	O
(	O
median	O
age	O
:	O
59	O
years	O
)	O
.	O

Of	O
the	O
66	O
patients	O
,	O
four	O
were	O
female	O
and	O
62	M-NUM
were	O
male	O
,	O
with	O
an	O
average	O
age	O
of	O
63.53±9.39	O
years	O
.	O

MATERIALS	O
AND	O
METHODSSubjects	O
were	O
breast	O
cancer	O
patients	O
who	O
participated	O
in	O
a	O
population-based	O
case–control	O
study	O
among	O
women	O
aged	O
40	O
years	O
or	O
younger	O
(	O
Bernstein	O
et	O
al	O
,	O
1994	O
)	O
.	O

Fresh	O
samples	O
of	O
HCC	O
tissues	O
and	O
pericarcinomatous	O
liver	O
tissues	O
(	O
PCLT	O
,	O
1	O
cm	O
away	O
from	O
the	O
carcinoma	O
)	O
were	O
obtained	O
from	O
25	O
(	O
22	M-NUM
male	O
and	O
3	F-NUM
female	O
)	O
patients	O
with	O
hepatocellular	O
carcinoma	O
who	O
underwent	O
hepatoectomy	O
at	O
Xiangya	O
Hospital	O
of	O
Central	O
South	O
University	O
(	O
CSU	O
)	O
.	O

The	O
patients	O
included	O
47	M-NUM
males	O
and	O
five	O
females	O
.	O

The	O
biopsies	O
were	O
derived	O
from	O
22	F-NUM
female	O
and	O
33	M-NUM
male	O
patients	O
.	O

CIN3	O
and	O
cancer	O
were	O
combined	O
in	O
most	O
analyses.Definition	O
of	O
the	O
cohortsThe	O
present	O
report	O
is	O
based	O
on	O
54	O
060	O
women	O
who	O
entered	O
the	O
study	O
on	O
or	O
after	O
1	O
July	O
1988	O
(	O
Figure	O
1Figure	O
1Definition	O
of	O
the	O
cohorts	O
.	O
)	O
.	O

All	O
analyses	O
are	O
based	O
on	O
the	O
remaining	O
49	O
655	O
women	O
from	O
whom	O
a	O
sample	O
for	O
HPV	O
assay	O
was	O
collected	O
at	O
a	O
routine	O
smear	O
test	O
that	O
gave	O
an	O
adequate	O
cytological	O
result.The	O
data	O
were	O
analysed	O
as	O
two	O
cohort	O
studies	O
(	O
Figure	O
1	O
)	O
.	O

The	O
retrospective	O
cohort	O
,	O
which	O
comprised	O
35	O
610	O
women	O
whose	O
previous	O
smear	O
was	O
cytologically	O
normal	O
and	O
routine	O
(	O
i.e	O
.	O

The	O
prospective	O
cohort	O
,	O
comprising	O
28	O
658	O
women	O
whose	O
entry	O
smear	O
was	O
normal	O
and	O
who	O
had	O
a	O
subsequent	O
cytologically	O
adequate	O
smear	O
,	O
were	O
followed	O
from	O
the	O
entry	O
smear	O
to	O
the	O
following	O
smear	O
.	O

Entry	O
spatulas	O
for	O
7278	F-NUM
of	O
these	O
women	O
were	O
included	O
in	O
the	O
age-stratified	O
random	O
sample	O
of	O
all	O
spatulas	O
.	O

HPV	O
analysis	O
was	O
performed	O
systematically	O
on	O
all	O
entry	O
spatulas	O
(	O
i	O
)	O
for	O
the	O
7278	F-NUM
eligible	O
women	O
in	O
the	O
age-stratified	O
random	O
sample	O
(	O
ii	O
)	O
for	O
all	O
CIN3	O
cases	O
diagnosed	O
at	O
entry	O
and	O
(	O
iii	O
)	O
for	O
subsequent	O
CIN3	O
cases	O
notified	O
within	O
the	O
study	O
period	O
(	O
i.e	O
.	O

The	O
outcome	O
measures	O
were	O
the	O
level	O
of	O
cancer-related	O
knowledge	O
,	O
psychosocial	O
functioning	O
,	O
treatment	O
decision-making	O
role	O
and	O
information	O
needs.ParticipantsThe	O
participants	O
were	O
67	M-NUM
men	O
recently	O
diagnosed	O
(	O
1	O
week	O
or	O
less	O
)	O
with	O
prostate	O
cancer	O
.	O

MATERIAL	O
AND	O
METHODSSurgical	O
resected	O
tissues	O
of	O
human	O
pancreatic	O
cancerThe	O
pancreatic	O
cancer	O
tissues	O
used	O
in	O
this	O
study	O
were	O
obtained	O
from	O
patients	O
(	O
10	M-NUM
male	O
;	O
13	F-NUM
female	O
)	O
undergoing	O
surgery	O
for	O
pancreatic	O
adenocarcinoma	O
in	O
the	O
National	O
Cancer	O
Center	O
Hospital	O
East	O
Japan	O
from	O
1999	O
to	O
2002	O
.	O

They	O
included	O
14	O
traditional	O
medicine	O
practitioners	O
(	O
4	F-NUM
females	O
and	O
10	M-NUM
males	O
)	O
,	O
86	O
locals	O
(	O
Male	O
:	O
Female	O
=	O
2:1	O
)	O
.	O

We	O
investigated	O
41	O
schizophrenic	O
patients	O
(	O
24	M-NUM
men	O
,	O
17	F-NUM
women	O
,	O
mean	O
age	O
63.3	O
±	O
7.0	O
years	O
)	O
who	O
met	O
the	O
DSM-IV	O
diagnostic	O
criteria	O
for	O
chronic	O
schizophrenia	O
(	O
APA	O
1994	O
)	O
and	O
23	O
age-	O
and	O
sex-matched	O
healthy	O
controls	O
(	O
15	O
men	O
,	O
8	O
women	O
,	O
mean	O
age	O
64.5	O
±	O
9.8	O
years	O
)	O
.	O

Materials	O
and	O
MethodsExperiment	O
DesignFourteen	O
healthy	O
right-handed	O
human	O
subjects	O
(	O
5	F-NUM
female	O
and	O
9	M-NUM
male	O
)	O
,	O
aged	O
21–30	O
years	O
,	O
participated	O
in	O
the	O
two-day	O
experiment	O
.	O

The	O
PDR	O
group	O
consisted	O
of	O
129	O
patients	O
(	O
66	M-NUM
men	O
and	O
63	F-NUM
women	O
)	O
,	O
and	O
their	O
average	O
age	O
was	O
62.3±0.72	O
years	O
(	O
range	O
47–79	O
years	O
)	O
.	O

The	O
non-PDR	O
group	O
(	O
n=175	O
)	O
was	O
composed	O
of	O
175	O
participants	O
(	O
80	M-NUM
men	O
and	O
95	F-NUM
women	O
)	O
whose	O
average	O
age	O
was	O
64.3±0.95	O
years	O
.	O

The	O
non-DM	O
group	O
had	O
186	O
participants	O
(	O
61	M-NUM
men	O
and	O
125	F-NUM
women	O
)	O
who	O
had	O
no	O
personal	O
history	O
or	O
clinical	O
signs	O
of	O
diabetes	O
.	O

The	O
specimens	O
were	O
obtained	O
from	O
8	M-NUM
males	O
and	O
9	F-NUM
females	O
(	O
mean	O
age	O
62.8	O
years	O
;	O
range	O
52–77	O
years	O
)	O
by	O
surgical	O
resection	O
at	O
the	O
National	O
Cancer	O
Hospital	O
East	O
and	O
were	O
immediately	O
frozen	O
in	O
liquid	O
nitrogen	O
and	O
stored	O
at	O
-80	O
°C	O
until	O
examined	O
.	O

The	O
phase	O
modulated	O
1-1	O
WE-SSFP	O
sequence	O
was	O
also	O
tested	O
in	O
one	O
42	O
year-old	O
male	O
patient	O
referred	O
for	O
CMR	O
to	O
characterize	O
a	O
cardiac	O
mass	O
seen	O
on	O
echocardiography	O
.	O

This	O
cohort	O
included	O
307	F-NUM
women	O
,	O
whose	O
exposure	O
to	O
cadmium	O
was	O
exclusively	O
environmental	O
.	O

MethodsSerum	O
samples	O
were	O
obtained	O
from	O
77	O
children	O
(	O
63	F-NUM
%	O
female	O
)	O
who	O
fulfilled	O
the	O
International	O
League	O
of	O
Associations	O
for	O
Rheumatology	O
(	O
ILAR	O
)	O
criteria	O
for	O
the	O
diagnosis	O
of	O
JIA	O
[	O
24	O
]	O
.	O

A	O
total	O
of	O
81	O
pediatric	O
controls	O
(	O
52	F-NUM
%	O
female	O
)	O
were	O
also	O
studied	O
with	O
a	O
mean	O
age	O
of	O
12	O
years	O
(	O
range	O
7–16	O
years	O
)	O
.	O

Participants	O
were	O
recruited	O
between	O
1993	O
and	O
1997	O
among	O
women	O
living	O
in	O
Utrecht	O
and	O
the	O
vicinity	O
who	O
attended	O
the	O
regional	O
population-based	O
breast	O
cancer-screening	O
program	O
.	O

This	O
resulted	O
in	O
15,236	F-NUM
women	O
in	O
the	O
total	O
cohort	O
and	O
1522	O
women	O
in	O
the	O
sub-cohort	O
(	O
as	O
the	O
control	O
group	O
)	O
at	O
baseline	O
.	O

MethodsPatient	O
characteristics	O
for	O
human	O
lung	O
tissue	O
experimentsHuman	O
parenchymal	O
lung	O
tissue	O
was	O
obtained	O
from	O
37	O
patients	O
(	O
15F/21M	O
)	O
undergoing	O
resection	O
for	O
carcinoma	O
and	O
1	O
male	O
undergoing	O
surgery	O
to	O
remove	O
a	O
cyst	O
at	O
Guy	O
's	O
Hospital	O
,	O
London	O
.	O

Seven	O
to	O
10	O
week	O
old	O
male	O
and	O
female	O
C57Bl/6	O
mice	O
were	O
treated	O
with	O
genistein	O
or	O
vehicle	O
(	O
control	O
)	O
,	O
and	O
infected	O
with	O
P.	O
berghei	O
ANKA	O
sporozoites	O
.	O

Only	O
two	O
patients	O
had	O
a	O
recurrence	O
in	O
the	O
entire	O
cancer	O
cohort	O
due	O
to	O
short	O
median	O
follow	O
up.The	O
total	O
number	O
of	O
cases	O
included	O
in	O
this	O
study	O
is	O
107	F-NUM
(	O
51	O
cancer	O
and	O
55	O
healthy	O
women	O
)	O
.	O

For	O
the	O
HPV	O
typing	O
,	O
a	O
random	O
age-stratified	O
sample	O
of	O
the	O
participants	O
was	O
taken	O
for	O
each	O
region	O
by	O
categorising	O
the	O
women	O
in	O
11	O
5-year	O
age	O
groups	O
:	O
⩽19	O
,	O
20–24	O
,	O
25–29	O
,	O
30–34	O
,	O
35–39	O
,	O
40–44	O
,	O
45–49	O
,	O
50–54	O
,	O
55–59	O
,	O
60–64	O
,	O
and	O
⩾65	O
years	O
.	O

As	O
the	O
youngest	O
and	O
oldest	O
groups	O
were	O
under-represented	O
(	O
<	O
100	O
women	O
)	O
,	O
the	O
total	O
samples	O
was	O
less	O
than	O
1100	O
per	O
region	O
.	O

Eighteen	O
healthy	O
adult	O
volunteers	O
(	O
10	M-NUM
male	O
and	O
8	F-NUM
female	O
;	O
mean	O
age	O
24	O
years	O
,	O
range	O
19–39	O
years	O
)	O
participated	O
in	O
this	O
study	O
at	O
the	O
Clinical	O
Trials	O
Unit	O
(	O
Txagorritxu	O
Hospital	O
,	O
Vitoria	O
,	O
Spain	O
)	O
.	O

In	O
the	O
experiment	O
,	O
the	O
samples	O
were	O
collected	O
from	O
17	O
normal	O
fertile	O
men	O
and	O
14	O
teratozoospermic	O
men	O
aged	O
between	O
21	O
to	O
57	O
.	O

Fourteen	O
(	O
6	O
males	O
,	O
8	O
females	O
;	O
aged	O
between	O
18	O
and	O
28	O
,	O
mean	O
age	O
23.36±2.87	O
years	O
)	O
were	O
assigned	O
with	O
human	O
intelligence	O
(	O
HI	O
)	O
and	O
fourteen	O
(	O
6	O
males	O
,	O
8	O
females	O
;	O
mean	O
age	O
24.12±2.35	O
years	O
,	O
aged	O
between	O
19	O
and	O
26	O
)	O
with	O
artificial	O
intelligence	O
(	O
AI	O
)	O
.	O

16	O
subjects	O
were	O
assigned	O
with	O
HI	O
stimuli	O
(	O
8	O
males	O
,	O
8	O
females	O
;	O
mean	O
age	O
20.81±1.80	O
years	O
)	O
and	O
16	O
subjects	O
with	O
AI	O
stimuli	O
(	O
8	O
males	O
,	O
8	O
females	O
;	O
mean	O
age	O
22.06±2.08	O
years	O
)	O
.	O

A	O
venous	O
blood	O
sample	O
was	O
taken	O
from	O
all	O
women	O
between	O
17	O
and	O
41	O
weeks	O
of	O
gestational	O
age	O
,	O
and	O
none	O
of	O
them	O
were	O
taking	O
insulin	O
when	O
the	O
auto-antibodies	O
were	O
determined	O
.	O

We	O
included	O
123	O
sCJD	O
cases	O
(	O
103	O
patients	O
had	O
4	O
available	O
regions	O
)	O
,	O
55	M-NUM
male	O
and	O
68	F-NUM
female	O
subjects	O
,	O
and	O
the	O
mean	O
age	O
at	O
death	O
was	O
68	O
(	O
range	O
,	O
24–90	O
years	O
)	O
.	O

In	O
addition	O
,	O
a	O
group	O
of	O
11	O
french	O
vCJD	O
cases	O
was	O
also	O
studied	O
,	O
comprising	O
of	O
4	M-NUM
male	O
and	O
7	F-NUM
female	O
subjects	O
.	O

MethodsStudy	O
subjects46	O
secundum	O
ASD	O
patients	O
(	O
20	M-NUM
men	O
,	O
26	F-NUM
women	O
;	O
mean	O
age	O
26.32	O
±	O
13.28	O
,	O
range	O
6	O
to	O
63	O
years	O
)	O
and	O
22	O
healthy	O
volunteers	O
matched	O
for	O
sex	O
and	O
age	O
(	O
12	O
men	O
,	O
10	O
women	O
;	O
mean	O
age	O
24.81	O
±	O
9.04	O
,	O
range	O
16	O
to	O
43	O
years	O
)	O
who	O
served	O
as	O
control	O
subjects	O
were	O
included	O
in	O
the	O
study	O
.	O

The	O
final	O
cohort	O
had	O
155	M-NUM
(	O
64.9	O
%	O
)	O
men	O
and	O
84	F-NUM
women	O
(	O
35.1	O
%	O
)	O
with	O
a	O
median	O
age	O
at	O
diagnosis	O
of	O
68	O
years	O
(	O
range	O
,	O
41–87	O
years	O
)	O
and	O
a	O
median	O
survival	O
time	O
of	O
36.9	O
months	O
(	O
range	O
,	O
1–113	O
months	O
)	O
.	O

A	O
total	O
of	O
78	F-NUM
%	O
of	O
the	O
invited	O
women	O
attended	O
the	O
screening	O
program	O
during	O
this	O
period	O
,	O
resulting	O
in	O
364,731	O
screened	O
women	O
50	O
to	O
69	O
years	O
of	O
age	O
.	O

We	O
were	O
able	O
to	O
use	O
these	O
data	O
,	O
where	O
503	F-NUM
women	O
aged	O
50	O
to	O
69	O
years	O
were	O
diagnosed	O
with	O
breast	O
cancer	O
between	O
1985	O
and	O
1994	O
.	O

Among	O
these	O
cases	O
,	O
433	F-NUM
women	O
(	O
86	O
%	O
)	O
had	O
registered	O
tumor	O
measurements	O
in	O
millimeters	O
.	O

Combining	O
sales	O
figures	O
with	O
risk	O
estimates	O
,	O
Bakken	O
and	O
colleagues	O
estimated	O
the	O
proportion	O
of	O
breast	O
cancer	O
cases	O
that	O
could	O
be	O
attributed	O
to	O
HRT	O
use	O
as	O
27	F-NUM
%	O
among	O
Norwegian	O
women	O
45	O
to	O
64	O
years	O
of	O
age	O
.	O

To	O
look	O
at	O
possible	O
age	O
differences	O
,	O
estimates	O
were	O
calculated	O
separately	O
for	O
women	O
aged	O
50	O
to	O
59	O
years	O
and	O
women	O
aged	O
60	O
to	O
69	O
years	O
,	O
in	O
addition	O
to	O
all	O
age	O
groups	O
combined	O
.	O

Materials	O
and	O
MethodsSubjectsNine	O
(	O
7	F-NUM
female	O
;	O
age	O
range	O
=	O
20–59	O
;	O
mean	O
age	O
=	O
26.3	O
)	O
healthy	O
,	O
right-handed	O
adult	O
volunteers	O
with	O
normal	O
hearing	O
participated	O
in	O
this	O
study	O
.	O

A	O
total	O
of	O
400	O
volunteers	O
(	O
108	M-NUM
males	O
and	O
292	F-NUM
females	O
)	O
with	O
RA	O
(	O
1987	O
revised	O
American	O
College	O
of	O
Rheumatology	O
criteria	O
[	O
13	O
]	O
)	O
were	O
assessed	O
.	O

Of	O
them	O
,	O
8	O
(	O
6	M-NUM
males	O
)	O
were	O
excluded	O
from	O
the	O
analyses	O
due	O
to	O
missing	O
data	O
for	O
body	O
composition	O
.	O

There	O
were	O
three	O
female	O
patients	O
aged	O
71	O
,	O
76	O
and	O
78	O
years	O
,	O
and	O
a	O
male	O
aged	O
77	O
years	O
.	O

A	O
total	O
of	O
16	O
patients	O
(	O
72	O
±	O
9	O
years	O
old	O
,	O
mean	O
±	O
standard	O
deviation	O
;	O
6	M-NUM
males	O
and	O
10	F-NUM
females	O
)	O
classified	O
as	O
having	O
OA	O
according	O
to	O
recognized	O
American	O
College	O
of	O
Rheumatology	O
clinical	O
criteria	O
were	O
included	O
in	O
this	O
study	O
[	O
20	O
]	O
.	O

Another	O
important	O
consideration	O
in	O
color	O
selection	O
is	O
that	O
approximately	O
8	O
%	O
of	O
men	O
and	O
0.5	O
%	O
of	O
women	O
are	O
color-blind	O
,	O
primarily	O
red-green	O
colorblindness	O
(	O
6	O
)	O
.	O

Methods2.1	O
Specimen	O
preparationTen	O
(	O
6	F-NUM
female	O
and	O
4	M-NUM
males	O
)	O
fresh-frozen	O
human	O
cadaveric	O
hand	O
specimens	O
(	O
age	O
55.2	O
±	O
5.6	O
years	O
)	O
were	O
used	O
in	O
this	O
study	O
.	O

Study	O
subjects	O
included	O
21	M-NUM
males	O
and	O
22	F-NUM
females	O
ranging	O
in	O
age	O
from	O
45	O
–	O
84	O
at	O
time	O
of	O
diagnosis	O
(	O
median	O
age	O
:	O
70	O
years	O
old	O
)	O
.	O

In	O
brief	O
,	O
522	O
overweight	O
(	O
BMI≥25	O
kg/m2	O
)	O
men	O
and	O
women	O
aged	O
40	O
to	O
65	O
years	O
with	O
IGT	O
participated	O
in	O
the	O
study	O
.	O

Prolonged	O
QTc	O
on	O
Electrocardiogram	O
(	O
ECG	O
)	O
was	O
defined	O
as	O
a	O
value	O
>	O
440	O
ms	O
and	O
>	O
460	O
ms	O
in	O
males	O
and	O
females	O
respectively	O
,	O
or	O
more	O
than	O
500	O
ms	O
if	O
there	O
was	O
ventricular	O
depolarization	O
abnormality	O
.	O

A	O
total	O
of	O
253	O
individuals	O
,	O
including	O
121	O
cases	O
with	O
exudative	O
AMD	O
(	O
71	M-NUM
males	O
and	O
50	F-NUM
females	O
)	O
and	O
132	O
control	O
subjects	O
(	O
68	O
males	O
and	O
64	O
females	O
)	O
participated	O
in	O
this	O
study	O
.	O

Forty	O
women	O
patients	O
with	O
RA	O
(	O
median	O
age	O
,	O
48.3	O
years	O
,	O
range	O
22–74	O
)	O
who	O
met	O
at	O
least	O
four	O
1987	O
American	O
College	O
of	O
Rheumatology	O
(	O
ACR	O
)	O
criteria	O
and	O
38	F-NUM
women	O
patients	O
with	O
fibromyalgia	O
(	O
median	O
age	O
44	O
,	O
range31–60	O
)	O
,	O
who	O
were	O
considered	O
as	O
control	O
group	O
,	O
were	O
included	O
in	O
this	O
study	O
.	O

RESEARCH	O
DESIGN	O
AND	O
METHODSWe	O
examined	O
55	O
patients	O
with	O
fulminant	O
type	O
1	O
diabetes	O
(	O
49	F-PER
%	O
female	O
,	O
median	O
age	O
at	O
onset	O
35.0	O
years	O
)	O
,	O
91	O
patients	O
with	O
classic	O
type	O
1A	O
diabetes	O
(	O
57	M-PER
%	O
female	O
,	O
median	O
age	O
at	O
onset	O
17.0	O
years	O
)	O
,	O
and	O
369	O
healthy	O
control	O
subjects	O
.	O

Control	O
samples	O
were	O
obtained	O
from	O
30	F-NUM
voluntary	O
women	O
without	O
cancer	O
.	O

Participants	O
were	O
recruited	O
between	O
1993	O
and	O
1997	O
among	O
women	O
living	O
in	O
Utrecht	O
and	O
vicinity	O
who	O
attended	O
the	O
regional	O
population-based	O
breast	O
cancer-screening	O
program	O
.	O

This	O
resulted	O
in	O
15,236	F-NUM
women	O
in	O
the	O
total	O
cohort	O
and	O
1519	O
women	O
in	O
the	O
sub-cohort	O
at	O
baseline	O
(	O
as	O
the	O
control	O
group	O
)	O
.	O

With	O
a	O
73	O
%	O
participation	O
,	O
the	O
cohort	O
included	O
6895	M-NUM
men	O
and	O
3413	F-NUM
women	O
at	O
study	O
entry	O
in	O
1985–1988	O
.	O

Thus	O
,	O
the	O
study	O
sample	O
with	O
complete	O
data	O
on	O
CRP	O
genotype	O
and	O
CRP	O
levels	O
for	O
the	O
cross-sectional	O
analyses	O
in	O
2003–2004	O
included	O
4941	O
(	O
3610	M-NUM
men	O
and	O
1331	F-NUM
women	O
)	O
individuals	O
aged	O
50–74	O
years	O
(	O
mean	O
age	O
61.0	O
)	O
.	O

For	O
these	O
analyses	O
,	O
the	O
study	O
sample	O
comprised	O
4435	O
(	O
3255	M-NUM
men	O
and	O
1180	F-NUM
women	O
)	O
individuals	O
,	O
a	O
sub-group	O
of	O
those	O
included	O
in	O
the	O
cross-sectional	O
analyses	O
,	O
who	O
in	O
addition	O
had	O
measurements	O
of	O
CRP	O
concentration	O
assessed	O
1991–1993	O
when	O
they	O
were	O
aged	O
39–64	O
years	O
(	O
mean	O
age	O
49.2	O
years	O
)	O
.	O

MethodsParticipantsFourteen	O
Western	O
Caucasian	O
(	O
6	O
males	O
,	O
9	O
females	O
)	O
and	O
14	O
East	O
Asian	O
(	O
7	M-NUM
males	O
,	O
8	F-NUM
females	O
)	O
young	O
adults	O
(	O
mean	O
age	O
24.4	O
years	O
and	O
23.2	O
years	O
respectively	O
)	O
participated	O
in	O
this	O
study	O
.	O

In	O
each	O
block	O
,	O
observers	O
were	O
instructed	O
to	O
learn	O
14	O
face	O
identities	O
randomly	O
displaying	O
either	O
neutral	O
,	O
happy	O
or	O
disgust	O
expressions	O
(	O
7	O
females	O
)	O
.	O

After	O
the	O
completion	O
of	O
the	O
face	O
recognition	O
tasks	O
,	O
observers	O
were	O
instructed	O
to	O
perform	O
a	O
face	O
categorization	O
by	O
race	O
task	O
on	O
56	O
Western	O
Caucasian	O
(	O
28	O
women	O
)	O
and	O
56	O
East	O
Asian	O
(	O
28	O
women	O
)	O
faces	O
.	O

Relatively	O
small	O
minimum	O
frontal	O
breadths	O
,	O
on	O
the	O
order	O
of	O
90	O
mm	O
[	O
3	O
]	O
to	O
96	O
mm	O
[	O
10	O
]	O
(	O
based	O
on	O
14	O
adult	O
male	O
crania	O
)	O
appear	O
to	O
be	O
common	O
among	O
early	O
Palauans	O
and	O
are	O
part	O
of	O
a	O
cranial	O
morphology	O
that	O
includes	O
relatively	O
large	O
maximum	O
lengths	O
and	O
breadths	O
and	O
normal	O
cranial	O
capacity	O
.	O

A	O
total	O
of	O
792	F-NUM
women	O
with	O
the	O
first	O
diagnosis	O
of	O
GDM	O
were	O
identified	O
during	O
the	O
study	O
period	O
.	O

Among	O
them	O
,	O
120	O
women	O
had	O
a	O
subsequent	O
pregnancy	O
by	O
March	O
2003	O
.	O

RESEARCH	O
DESIGN	O
AND	O
METHODSOur	O
study	O
population	O
consisted	O
of	O
67	O
offspring	O
(	O
39	F-NUM
women	O
and	O
28	M-NUM
men	O
)	O
with	O
an	O
average	O
age	O
of	O
23.8	O
±	O
4.50	O
years	O
.	O

It	O
was	O
not	O
possible	O
to	O
obtain	O
detailed	O
information	O
about	O
weight	O
gain	O
during	O
pregnancy	O
or	O
in	O
early	O
life.Offspring	O
of	O
obese	O
mothersThe	O
Ob	O
group	O
consisted	O
of	O
52	O
subjects	O
(	O
31	F-NUM
women	O
and	O
21	M-NUM
men	O
)	O
who	O
were	O
offspring	O
of	O
22	O
obese	O
mothers	O
.	O

The	O
control	O
group	O
consisted	O
of	O
15	O
offspring	O
(	O
8	F-NUM
women	O
and	O
7	M-NUM
men	O
)	O
of	O
6	O
normal-weight	O
(	O
BMI	O
<	O
25	O
kg/m2	O
)	O
mothers	O
,	O
who	O
met	O
the	O
inclusion	O
criteria	O
.	O

Basic	O
characteristics	O
of	O
the	O
UK	O
study	O
subjects	O
are	O
presented	O
in	O
Table	O
1.To	O
validate	O
the	O
relevance	O
of	O
the	O
PLCL1	O
gene	O
to	O
HF	O
,	O
we	O
used	O
a	O
Chinese	O
sample	O
containing	O
403	F-NUM
female	O
subjects	O
including	O
226	O
with	O
low	O
trauma	O
osteoporotic	O
HF	O
and	O
177	O
controls	O
.	O

Materials	O
and	O
MethodsSubjectsFifty	O
undergraduate	O
students	O
(	O
32	M-NUM
females	O
,	O
18	F-NUM
males	O
;	O
mean	O
±	O
SD	O
age	O
:	O
20.7	O
±	O
3.1	O
years	O
)	O
with	O
more	O
than	O
10	O
years	O
of	O
education	O
(	O
mean	O
±	O
SD	O
:	O
13.6	O
±	O
2.5	O
years	O
of	O
education	O
)	O
took	O
part	O
in	O
the	O
study	O
.	O

MethodsParticipants	O
CharacteristicsNine	O
highly	O
trained	O
and	O
10	M-NUM
normally	O
active	O
males	O
served	O
as	O
participants	O
in	O
this	O
study	O
(	O
see	O
descriptive	O
data	O
provided	O
in	O
Table	O
1	O
)	O
.	O

Logistic	O
regression	O
,	O
which	O
had	O
been	O
adjusted	O
for	O
age	O
,	O
was	O
used	O
to	O
evaluate	O
risk	O
factors	O
of	O
fatty	O
liver	O
in	O
male	O
and	O
female	O
type	O
2	O
diabetes	O
mellitus	O
patients	O
.	O

The	O
average	O
retirement	O
age	O
was	O
68.2	O
for	O
men	O
and	O
66.9	O
for	O
women	O
in	O
2004	O
(	O
Korea	O
Labor	O
Institute	O
)	O
.	O

NPs	O
ranged	O
in	O
size	O
from	O
50–200	O
nm	O
and	O
in	O
some	O
situations	O
formed	O
clumps	O
(	O
please	O
see	O
Miller	O
et	O
al	O
2004	O
)	O
.Animals	O
and	O
surgeryAdult	O
male	O
(	O
3	O
kg	O
)	O
New	O
Zealand	O
white	O
rabbits	O
(	O
n	O
=	O
9	M-NUM
total	O
)	O
were	O
fed	O
LabDiet	O
hi-fiber	O
rabbit	O
chow	O
ad	O
libitum	O
and	O
were	O
maintained	O
in	O
individual	O
cages	O
(	O
12	O
hr	O
light/12	O
hr	O
dark	O
cycle	O
)	O
.	O

(	O
b	O
)	O
The	O
back	O
view	O
,	O
with	O
circular	O
window	O
for	O
crocodile	O
clip	O
connection.Ten	O
healthy	O
human	O
volunteers	O
(	O
8	M-NUM
men	O
and	O
2	F-NUM
women	O
)	O
,	O
aged	O
between	O
22	O
and	O
35	O
years	O
(	O
mean	O
=	O
26.8	O
,	O
SD	O
=	O
3.7	O
)	O
,	O
with	O
no	O
history	O
of	O
dermatological	O
disease	O
participated	O
in	O
this	O
study	O
.	O

MethodsParticipantsFifty-eight	O
right-handed	O
subjects	O
between	O
the	O
ages	O
of	O
18	O
and	O
28	O
(	O
mean	O
age	O
in	O
years-20.9±4.0	O
[	O
SD	O
]	O
;	O
19	F-NUM
females	O
)	O
were	O
paid	O
for	O
their	O
participation	O
in	O
the	O
study	O
.	O

The	O
population	O
size	O
used	O
for	O
the	O
calculation	O
of	O
incidence	O
was	O
787,836	O
inhabitants	O
(	O
INSEE	O
,	O
April	O
2006	O
)	O
.Detection	O
of	O
chikungunya	O
infectionsFor	O
the	O
rapid	O
survey	O
in	O
pregnant	O
women	O
,	O
100	O
microliters	O
of	O
stored	O
sera	O
already	O
available	O
in	O
outpatient	O
laboratories	O
were	O
used	O
.	O

Of	O
the	O
controls	O
,	O
15	M-NUM
were	O
male	O
and	O
8	F-NUM
were	O
female	O
.	O

MethodsPatients	O
and	O
controls478	O
unrelated	O
individuals	O
(	O
320	M-NUM
males	O
and	O
158	F-NUM
females	O
)	O
were	O
diagnosed	O
as	O
TCP	O
(	O
n	O
=	O
286	O
)	O
or	O
FCPD	O
(	O
n	O
=	O
192	O
)	O
patients	O
based	O
on	O
the	O
established	O
WHO	O
criteria	O
[	O
28	O
]	O
.	O

Six	O
hundred	O
and	O
sixty	O
one	O
age	O
matched	O
individuals	O
(	O
332	M-NUM
males	O
and	O
329	F-NUM
females	O
)	O
comprising	O
of	O
259	O
Dravidians	O
and	O
402	O
Indo-Europeans	O
without	O
any	O
complaints	O
and	O
evidence	O
of	O
pancreatitis	O
were	O
included	O
as	O
controls	O
[	O
17,20	O
]	O
.	O

The	O
control	O
group	O
consisted	O
of	O
subjects	O
(	O
11	M-NUM
males	O
,	O
6	F-NUM
females	O
;	O
11	O
non-smokers	O
,	O
5	O
smokers	O
,	O
1	O
subject	O
with	O
unknown	O
smoking	O
history	O
;	O
age	O
42.2	O
±	O
15.7	O
yrs	O
)	O
undergoing	O
BAL	O
within	O
medical	O
examination	O
for	O
'non-inflammatory	O
condition	O
'	O
e.g	O
.	O

The	O
subgroups	O
in	O
the	O
second	O
cohort	O
were	O
based	O
on	O
gender	O
(	O
37	M-NUM
males/43	O
females	O
)	O
,	O
smoking	O
status	O
(	O
23	O
smokers/56	O
non-smokers	O
)	O
,	O
and	O
presence	O
of	O
lung	O
disease	O
(	O
63	O
sarcoidosis	O
patients/17	O
control	O
subjects	O
)	O
.	O

Given	O
the	O
probable	O
hormonal	O
action	O
of	O
organochlorines	O
on	O
bone	O
,	O
and	O
given	O
the	O
very	O
large	O
difference	O
in	O
osteoporosis	O
incidence	O
in	O
males	O
and	O
females	O
after	O
60	O
years	O
of	O
age	O
,	O
it	O
seemed	O
most	O
appropriate	O
to	O
assess	O
the	O
relationships	O
between	O
organo-chlorines	O
and	O
BMD	O
measures	O
in	O
males	O
and	O
females	O
separately	O
.	O

Materials	O
and	O
MethodsSubjectsWe	O
performed	O
functional	O
magnetic	O
resonance	O
(	O
MR	O
)	O
measurements	O
on	O
18	O
right-handed	O
healthy	O
human	O
volunteers	O
(	O
8	M-NUM
males	O
and	O
10	F-NUM
females	O
,	O
mean	O
age	O
25	O
years	O
,	O
range	O
:	O
20–33	O
)	O
.	O

Case	O
study	O
:	O
methods	O
,	O
materials	O
,	O
and	O
human	O
resourcePatientA	O
woman	O
aged	O
50	O
had	O
a	O
symptomatic	O
varicose	O
equally	O
on	O
both	O
sides	O
(	O
CEAP-classification	O
:	O
C2EpAs2As3As5Ap17Ap18Pr	O
)	O
and	O
surgery	O
was	O
indicated	O
.	O

Prospective	O
design	O
study	O
:	O
Methods	O
,	O
materials	O
and	O
human	O
resourcesHuman	O
resourceA	O
woman	O
aged	O
50	O
with	O
colored	O
skin	O
and	O
cellulite	O
grade	O
3	O
at	O
her	O
thighs	O
and	O
buttocks	O
had	O
to	O
have	O
surgery	O
on	O
both	O
hips	O
.	O

METHODSNineteen	O
right-handed	O
participants	O
(	O
aged	O
19–33	O
,	O
10	F-NUM
female	O
)	O
all	O
had	O
normal	O
or	O
corrected-to-normal	O
vision	O
and	O
were	O
native	O
speakers	O
of	O
a	O
Latin-alphabet	O
language	O
.	O

Twenty-one	O
men	O
and	O
6	F-NUM
women	O
were	O
included	O
in	O
the	O
study	O
.	O

